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1. Suncheonoside A-D, benzothioate glycoside from marine-derived 
Streptomyces sp. 
A marine-derived Streptomyces strain, SSC21, was isolated from the 
sediment of Suncheon Bay, Republic of Korea. Chemical analysis of the 
bacterial strain resulted in the isolation of four new metabolites, 
suncheonosides A-D (1-4), each bearing a sulfur atom. The planar structures 
of the suncheonosides were identified as hexa-substituted benzothioate 
glycosides by combined spectroscopic analyses. Analysis of the 
configuration of the sugar moieties based on ROESY NMR correlations, 1-
bond 1H-13C coupling constant analysis, and chemical derivatizations 
elucidated that the suncheonosides incorporate only L-rhamnose. 
Suncheonosides A, B, and D promoted adiponectin production in a 
concentration-dependent manner during adipogenesis in human 
mesenchymal stem cells, suggesting anti-diabetic potential.
II
2. JS8 A and B, novel bacterial flavonoid, from Streptomyces sp. 
associated with white grub Protaetia brevitarsis seulensis. 
Investigation of secondary metabolites of bacteria associated with 
eukaryotic hosts has become a promising approach to discover novel 
bioactive compounds. In search for new bioactive chemotypes, I have been 
focusing on secondary metabolites of bacterial strains associated in the gut 
of a white grub of Protaetia brevitarsis seulensis. The secondary metabolite 
profiles of the 80 actinobacterial strains isolated from the gut of a P. 
brevitarsis grub were chemically analyzed by LC/MS. This chemical 
analysis led to the discovery of two new flavonoid-like compounds, which 
are dominantly found in plants but really uncommon as bacterial 
metabolites. The epimeric compounds JS8A and B (6-7) were purified by 
HPLC using a chiral column (a polysaccharide-based immobilizing 
cellulose to silica gel). Their structures were determined mainly by 
spectroscopic analysis of NMR and mass data. The absolute configurations 
were established by time-controlled acetylation followed by the application 
of the modified Mosher’s method using MTPA. Moreover, the comparative 
full genome analysis of the strain JS8 and the producer (CNB-689) of 
actionflavoside, will be discussed along with their structures.
3. Actinomadurol, an antibacterial norditerpenoid from a rare 
actinomycete, Actinomadura sp. KC-191
A new secondary metabolite, actinomadurol (13), was isolated 
III
along with the known compound JBIR-65 (14) from a rare actinomycete, 
Actinomadura strain KC 191. The structure of 13 was established as a rare 
member of the bacterial C-19 norditerpenoid class by NMR data and ECD 
calculations. The absolute configuration of 14, which was previously 
reported without stereochemical analysis, was determined by using the 
modified Mosher’s method and ECD calculations. Actinomadurol (13) 
exhibited potent antibacterial activity against pathogenic strains, such as 
Staphylococcus aureus, Kocuria rhizophila and Proteus hauseri (MIC = 
0.39 ~ 0.78 mg/mL), whereas JBIR-65 (14) showed no antibacterial activity.
4. Deinococcucins A−D, aminoglycolipids from Deinococcus sp., a gut 
bacterium of the carpenter ant Camponotus japonicus. 
Four new aminoglycolipids, deinococcucins A-D (18-21), were 
discovered from a Deinococcus sp. strain isolated from the gut of queen 
carpenter ants, Camponotus japonicus. The structures of deinococcucins A-
D were elucidated as a combination of N-acetyl glucosamine, 2,3-
dihydroxypropanoic acid, and an alkyl amine with a C16 or C17 hydrocarbon 
chain primarily based on 1D and 2D nuclear magnetic resonance (NMR) 
and mass spectroscopic data. The exact location of the olefinic double bond 
in deinococcucins C-D (20-21) was assigned based on the liquid 
chromatography-mass spectroscopy (LC/MS) data obtained after olefin
metathesis. The absolute configurations of the N-acetyl glucosamine and 
2,3-dihydroxy moieties were determined through gas chromatography-mass 
IV
spectroscopy (GC/MS) analysis of authentic samples and phenylglycine 
methyl ester (PGME)-derivatized products, respectively. Deinococcucins A 
and C displayed significant induction of quinone reductase in murine Hepa-
1c1c7 cells.
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Marine-derived bioactive compounds are currently considered 
tremendous chemical resources for drug discovery.1 Early marine natural 
products research primarily focused on marine invertebrates, ultimately 
resulting in the development of several marketed drugs. The representative 
anticancer drug Halaven was originally derived from a marine sponge, 
whereas the painkiller Prialt was derived from a cone snail.2 In addition, the 
anticancer agent Yondelis was developed from a marine tunicate.2 However, 
over the past five years, the number of publications about the chemistry of 
marine invertebrates has remained static or even decreased, whereas marine 
microorganisms are now increasingly spotlighted as an emerging source of 
new bioactive natural products.3 Among marine-derived bacteria, 
actinobacteria constitute important and potential taxa with respect to 
chemical diversity.4 The number of chemical reports on marine 
actinomycetes has rapidly increased over the past decade, and the rates of
increase over the past five years are even higher.3
In our search for new bioactive compounds from marine actinobacteria,5 I
selectively isolated actinomycete strains from marine sediment samples 
from Suncheon Bay, Republic of Korea. Suncheon Bay is a tideland with 
high biodiversity that provides habitats for migratory birds, various plants 
and animals as well as microorganisms.6 Actinomycete strains from 
Suncheon Bay sediments were subjected to chemical profiling by LC/MS 
analysis. Through the profiling process, one of the strains, Streptomyces sp. 
SSC21, was identified to produce a series of compounds, each containing a 
３
sulfur atom, based on mass spectroscopic data ([M+Na]+:[M+2+Na]+ ≈
100:5).7 This information, along with corresponding UV and mass spectra, 
suggested that these compounds were unlikely to have been previously 
reported, thus prompting further chemical analysis. In this paper, I discuss 
the isolation and identification of the structures of the sulfur-bearing 
compounds, named suncheonosides A-D (1-4), and their biological activity 
with respect to insulin sensitivity.
Investigation of secondary metabolites of bacteria associated with 
eukaryotic hosts has become a promising approach to discover novel 
bioactive compounds. In search for new bioactive chemotypes, I have been 
focusing on secondary metabolites of bacterial strains associated in the gut 
of a white grub of Protaetia brevitarsis seulensis. The secondary metabolite 
profiles of the 80 actinobacterial strains isolated from the gut of a P. 
brevitarsis grub were chemically analyzed by LC/MS. This chemical 
analysis led to the discovery of two new flavonoid-like compounds, which 
are dominantly found in plants but really uncommon as bacterial 
metabolites. The epimeric compounds JS8A and B (6-7) were purified by 
HPLC using a chiral column (a polysaccharide-based immobilizing 
cellulose to silica gel). Their structures were determined mainly by 
spectroscopic analysis of NMR and mass data. The absolute configurations 
were established by time-controlled acetylation followed by the application 
of the modified Mosher’s method using MTPA. Moreover, the comparative 
４
full genome analysis of the strain JS8 and the producer (CNB-689) of 
actionflavoside, will be discussed along with their structures.
The discovery of new antibiotics is constantly required because of the 
continuing development of antibiotic resistance and the side effects of 
current antibiotics.16 Microbial natural products remain the most propitious 
source of novel antibiotics. Filamentous actinobacteria have a unique ability 
to produce natural antibiotic compounds;17 notably members of the genus 
Streptomyces which are the source of over 70% actinobacterial bioactive 
compounds.18 However, recently rare actinobacteria, that is, representatives 
of genera with lower isolation rates than Streptomyces strains, are being 
increasingly recognized as a potential source of novel antibiotics19 following 
the discovery of epoch-making antibacterial drugs, as exemplified by the 
isolation of erythromycin from Saccharopolyspora erythraea,20 and 
vancomycin from Amycolatopsis orientalis.21 In more recent times novel 
bioactive compounds have been isolated from rare actinobacteria classified 
in poorly studied genera such as Salinispora22 and Verrucosispora.23
In our search for new bioactive compounds, I focused on the secondary 
metabolites of rare actinobacteria, as illustrated by the discovery of a 
structurally new benzofuran glycoside and indole alkaloids from an 
Amycolatopsis strain isolated from a marine sponge.8 A continuation of 
these studies led us to Actinomadura strain KC 191 which was seen to 
inhibit neighboring bacterial colonies on isolation plates seeded with a 
５
suspension of an agricultural soil sample. Extracts of strain KC 191 showed 
significant antibacterial activity against Bacillus subtilis, Staphylococcus 
aureus, Kocuria rhizophila, Proteus hauseri and Salmonella enterica strains 
(MIC = 0.39 ~ 3.12 mg/mL), prompting the scale-up of the culture. 
Comprehensive chemical analysis of the resultant extracts led to the 
identification of a new antibacterial norditerpenoid, actinomadurol (13), and 
its congener, JBIR-65 (14), which was previously reported albeit without 
stereochemical analysis.25 Here, I report on the structural determination, 
including the absolute configurations of actinomadurol (13) and JBIR-65 
(14) and their antibiotic activities.
Microbes in symbiotic insect ecosystems have recently been recognized 
as a tremendous reservoir of bioactive small molecules for drug discovery.45-
47 However, only a handful of insect systems have been investigated for 
microbial compounds, even though the class Insecta is estimated to contain 
approximately 5 million species in 28 orders.48 Representative chemical 
studies on the bioactive small molecules produced by insect-associated 
microbes have involved the southern pine beetle Dendroctonus frontali49-51
and the dung beetle Copris tripartitus52-55 in the order Coleoptera, the 
fungus-growing termite Macrotermes natalensis56-58 in the order Blattodea, 
the mantis Tenodera aridifolia59 in the order Mantodea, the grasshopper 
Oxya chinensis in the order Orthoptera,60,61 and the fungus-growing ants 
６
(Apterostigma dentigerum and Trachymyrmex cornetzi)62,63 and the wasps 
(Sceliphron caementarium64,65 and Philanthus triangulum66,67) in the order 
Hymenoptera. 
Hymenoptera, which harbors more than 125,000 described species and 
220,000 estimated species, is one of the four most speciose insects.68 This 
order distinctively encompasses most of the eusocial insects. Ants are 
common and representative eusocial insects belonging to the family
Formicidae in the order Hymenoptera.69 Their successful adaptation in 
diverse environments has been explained by their organized social life 
cycles. As highlighted in the pioneering chemical studies of symbiotic 
bacteria in fungus-growing ants,62,63 bacterial associations with ants can be a 
general phenomenon. Therefore, the chemical investigation of bacterial 
secondary metabolites in ant ecosystems may be an efficient strategy to 
discover new bioactive small molecules. This study focused on the 
ecosystem of the carpenter ant, Camponotus japonicus, which is a dominant 
ant species in East Asia.70 I collected carpenter ants in Seoul Grand Park, 
Republic of Korea, and isolated bacterial strains from the ant specimens. 
Chemical analysis of the bacterial metabolites by liquid chromatography-
mass spectroscopy (LC/MS) revealed that strain SJN1, which was most 
closely related to Deinococcus xinjiangensis and isolated from the gut of 
queen specimens, produced a series of previously unreported compounds 
that were invisible under UV detection but distinctly detected in mass 
spectra ([M+H]+ ions at m/z 531~547). Further scaling up the culture of 
７
SJN1 and chromatographic isolation of these compounds by HPLC with 
refractive index (RI) detection resulted in the discovery of four new 
aminoglycolipids, deinococcucins A-D (18-21). Here, I report the structural 
determination, including the absolute configurations, and the biological 
activities of deinococcucins A-D (18-21), rare metabolites from the genus 
Deinococcus.
８
II. Studies on the secondary 




1. Suncheonoside A-D, benzothioate 
glycoside from marine-derived 
Streptomyces sp.
１０
II.1.1. Results and discussion
Suncheonoside A (1) was isolated as a white powder. The molecular 
formula of 1 was assigned as C19H28O7S based on HRFAB mass 
spectrometric data and 1H and 13C NMR data (Table 1). The 1H and HSQC 
NMR spectra of 1 in pyridine-d5 showed a proton at δH 5.77 directly bound 
to a dioxygenated carbon at δC 107.2, four methine protons between 4.87 
ppm and 4.41 ppm correlated with oxygenated sp3 carbons between 72.1 
and 73.4, a methine proton (δH 3.39) attached to an aliphatic carbon (δC
32.1), three singlet methyl groups (δH 2.58- δC 11.4; δH 2.48-δC 14.2; δH 
2.41- δC 12.8), and three doublet methyl groups (δH 1.72- δC 18.6; δH 1.41-δC 
21.6; δH 1.38- δC 21.7). In contrast to the 
1H NMR spectrum, which showed 
only sp3 carbon-bound protons, the 13C NMR spectrum exhibited one 
carbonyl carbon at 197.3 ppm and six sp2 carbons between 157.4 and 116.7 
ppm, along with the five oxygenated carbons and seven aliphatic carbons 
observed in the HSQC NMR spectrum.
Given this information, the structure of compound 1 was determined by a 
combined analysis of COSY and HMBC NMR experiments. First, the 
HMBC spectrum clearly demonstrated the presence of a hexa-substituted 
benzenoid system. The position of one aryl methyl group (C-8) at δH 2.58 
was assigned to C-3 based on three strong HMBC correlations of H3-8 to C-
3 (δC 116.7) and two oxygen-bearing carbons (C-2 at δC 152.4 and C-4 at δC 
157.4). The other aryl methyl group (C-9) at δH 2.48 was determined to be 
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located at C-5 based on the distinct HMBC couplings of H3-9 to one 
oxygen-bearing carbon (C-4 at δC 157.4) and two double-bond carbons (C-5 
at δC 140.9 and C-6 at δC 120.5). The H3-8/C-4 and H3-9/C-4 HMBC 
correlations clearly secured the connectivity of C-3 to C-4. The COSY 
correlations of the aliphatic methine proton H-10 (δH 3.39) to two doublet 
methyl protons (H3-11 at δH 1.38 and H3-12 at δH 1.41) suggested the 
formation of an isopropyl group. The 1H-13C long-range coupling detected 
from these geminal methyl groups to C-6 placed the isopropyl group at C-6. 
The HMBC correlations from H-10 and H3-9 to C-5 and C-6 established a 
C-5-C-6 linkage. The ring closure connectivity from C-1 to C-2 was 
deduced by the double-bond chemical shifts of these carbons and the 
number of double-bond carbons, thus indicating the formation of a six-
membered aromatic system. 
Analysis of the COSY and HMBC NMR data revealed a hexose structure. 
1H-1H homonuclear couplings revealed the formation of a spin system from 
H-1¢ (δH 5.77) to H3-6¢ (δH 1.72) COSY correlations. H-1¢/C-5¢ and H-5¢/C-
1¢ HMBC correlations established that a hexose underwent ring closure. The 
hexose ring was connected to the hexa-substituted aromatic moiety through 
an ether functional group, based on the HMBC correlation from H-1¢ to C-2. 
These assignments consequently left the C-1 position to be substituted by a 
functional group composed of an unused carbonyl carbon at δC 197.3, a 
singlet methyl group (δH 2.41-δC 12.8), and a sulfur atom. The HMBC 
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correlation from the singlet methyl protons to the carbonyl carbon suggested 
two possible functional groups, S-methyl methanethioate and ethanethioate. 
The chemical shift (δC 12.8) of the methyl group clearly indicated S-methyl 
methanethioate, thus assigning the position of the thioester carbon (C-7) as 
between C-1 and the S-methyl group (C-13). Therefore, the planar structure 
of suncheonoside A (1) was elucidated as a new benzothioate glycoside 
(Figure 1). 
The relative configuration of the sugar was established by analyzing 1H-
13C and 1H-1H coupling constants and ROESY NMR through-space 
correlations. The magnitude of 1JCH (170 Hz) between C-1¢ and H-1¢ was 
clearly indicative of an α-configuration,8 placing the anomeric proton (H-1¢) 
at an equatorial position. The large 1H-1H vicinal coupling constant (9.0 Hz) 
between H-3¢ and H-4¢ established their anti-relationship and, therefore, 
axial positions. The equatorial position of H-2¢ was assigned based on the 
ROESY correlation between H-2¢ and H-3¢. The H-3¢/H-5¢ 1,3-ROESY 
correlation established an axial position for H-5¢ and consequently an 
equatorial position for the C-6¢ methyl group. This assignment was also 
supported by the H-4¢/H3-6¢ ROESY correlation. Therefore, the hexose 
moiety was determined to be rhamnose (Figure 2). 
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Figure 2. The observed strong ROESY correlations in the hexose moiety 
in 1-4.
To date, rhamnose sugar has been found to occur only in the L-form in 
nature, and thus, this moiety has often been assumed to possess an L-
configuration in nature without precise stereochemical verification.8 To 
establish the absolute configuration of rhamnose in a rigorous manner, 
suncheonoside A (1) was first subjected to acid hydrolysis. The hydrolysate 
and authentic L- and D-rhamnose samples were separately derivatized with 
L-cysteine methyl ester hydrochloride and σ-tolyl isothiocyanate.9 Based on 
LC/MS analysis of the derivatives, the rhamnose moiety in suncheonoside A 
was determined to possess an L-configuration.
Suncheonoside B (2) was purified as a white powder, the molecular 
formula of which was determined to be C20H30O7S based on the 
corresponding HRFAB mass spectrometric data and 1H and 13C NMR data 
(Table 1). The 1H and 13C NMR spectra of 2 in pyridine-d5 were observed to 
be highly similar to those of 1. Detailed examination of the 1D and 2D 
NMR data of 2 revealed the existence of the S-methyl benzothioate and 
rhamnose moieties analogous to those of 1. The most noticeable difference 
in 2 compared to suncheonoside A was the occurrence of a methoxy group 
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(δH 3.68-δC 62.3). The group was readily accommodated by replacing the 4-
OH hydroxy group in 2, as indicated by the HMBC correlation of 4-OMe to 
C-4 (dC 157.8). The absolute configuration of rhamnose in suncheonoside B 
(2) was also assigned an L-configuration by the chemical derivatization and 
LC/MS analysis method discussed above. Therefore, the structure of 
suncheonoside B (2) was elucidated as a methoxy analog of 1 on C-4. 
Suncheonoside C (3) was isolated as a white powder. Its molecular 
formula (C20H30O7S) was determined to be identical to that of 
suncheonoside B (2) based on HRFAB mass spectrometric data and 1H and 
13C NMR data (Table 1). The NMR, UV, and IR spectroscopic features of 3
were highly analogous to those of 2. Further investigation of the 1H, 13C, 
COSY, HSQC, HMBC and ROESY NMR spectra indicated that the 
structure of suncheonoside C (3) was very similar to that of suncheonoside 
B (2), except for the positions of the methoxy group and the sugar moieties. 
The methoxy protons (dH 3.68) displayed an HMBC correlation to C-2 (dC
152.8), placing the methoxy group at C-2 whereas the H-1²/C-4 long-range 
coupling connected the sugar at C-4. Stereochemical analysis of the sugar 
moiety established that this unit is also L-rhamnose.
In addition to suncheonosides A-C (1-3), suncheonoside D (4) was purified 
as a white powder. The molecular formula of 4 was determined to be 
C25H38O11S based on HRFAB analysis and 
1H and 13C NMR data (Table 1). 
Interpretation of the 1H, 13C, COSY, HSQC and HMBC NMR spectra 
１５
suggested that suncheonoside D (4) has a structure similar to the structures 
of other congeners that have S-methyl benzothioate and rhamnose moieties. 
Further analysis of 1D and 2D NMR data indicated that compound 4
possessed two hexoses that consisted of two anomeric protons (δH 5.68-dC
107.3 and dH 5.54-dC 106.5) and eight protons attached to oxygen-bearing 
carbons between 4.98 ppm and 4.44 ppm as well as two methyl groups (δH 
1.66 and 1.66) not belonging to the benzothioate unit. These two hexoses
were constructed mainly by COSY correlations (Figure 1) and connected to 
C-2 and C-4 in the benzothioate aglycone based on the H-1¢/C-2 and H-
1²/C-4 HMBC correlations. Analysis of the coupling constants 1JCH and 
3JHH and ROESY correlations confirmed that these two units are rhamnose. 
The absolute configurations of the rhamnose moieties were also determined 
to both be L-configurations by chemical derivatization and chromatographic 
analysis, analogously to suncheonosides A-C.
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Figure 1. Key 1H-1H COSY and HMBC correlations of 1-4.
The glycosidic bond conformations between the aglycone and the sugar 
moieties of the suncheonosides were analyzed using ROESY NMR 
correlations. In suncheonoside A (1), the H3-8 showed ROESY correlations 
with H-3¢ and H-5¢. Based on these correlations, the C-8 methyl group, not 
the benzene ring, is located on the top of the rhamnose ring, possibly 
minimizing steric repulsion between the two rings (Figure 3). This 
conformation was also well supported by the energy-minimized structure 










Figure 3. DFT-calculation-based minimum energy conformation of 
suncheonoside A (1) with the key ROESY correlations and distances between 
protons.
The conformation of suncheonoside B (2), an O-methyl version of 1, is 
assumed to be analogous to that of 1. In the case of suncheonoside C (3), 
H3-8 displayed ROESY correlations with H-1² and H-3² and H3-9 displayed 
ROESY correlations with H-1² and H-5². These observations illustrated that 
the C-8 and C-9 methyl groups are oriented toward the top face of the 
hexose where the axial protons H-3² and H-5² are located. This 
conformation was also supported by the DFT calculations (Supporting 
Information Figure S26). Finally, the conformation of suncheonoside D 
bearing two sugars at positions C-2 and C-4 of the aromatic ring was 
analyzed by ROESY correlations. H3-8 of the aglycone part showed ROESY 
correlations with H-2¢ and H-3¢ in 2-rhamnose and with H-3² in 4-rhamnose. 
In addition, H3-9 was correlated with H-1² and H-5² in the ROESY 
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spectrum. These correlations are sufficiently rationalized by DFT 
calculations (Figure S27). 
Hexa-substituted benzoid structures bearing a thioester are uncommon, 
with only a few examples observed in nature. Resorthiomycin I, which 
exhibits antitumor and antibiotic activities, is derived from Streptomyces 
collinus10, and the anticancer enediyne compounds calicheamicins, derived 
from Micromonospora echinospora11, are incorporated with hexa-
substituted thiobenzoate moieties. Relatively recently, the aglycone of the 
suncheonosides S-methyl-2,4-hydroxy-6-isopropyl-3,5-dimethylbenzothioat
(5) was reported from a marine-derived Streptomyces sp. without biological 
evaluation.12 Hexa-substituted benzothioates are rarely found from sources 
other than actinobacteria featuring mortivinactin B from the fungus 
Mortierella vinacea13 and polycarpamine B from the marine ascidian 
Polycarpa auzata.14
The biological activities of suncheonosides A-D (1-4) were investigated to 
improve the insulin sensitivity related to anti-diabetic drug discovery. In a 
phenotype-based assay for searching for new compounds to regulate 
adipogenesis in human bone marrow mesenchymal stem cells (hBM-MSCs), 
the suncheonosides (10 mM) promoted adipogenesis in hBM-MSCs (Figure 
4a and 4b). When adipogenesis in hBM-MSC is induced by co-treatment 
with insulin, dexamethasone, and isobutylmethylxanthine (IBMX) (IDX 
medium), adipocyte differentiation can be promoted by a compound that 
１９
improves insulin sensitivity.15 hBM-MSCs were treated with the 
suncheonosides (1-4) in IDX media for 6 days, and the level of lipid droplet 
formation in the hBM-MSCs was measured by Oil Red O (ORO) staining 
(Figure 4a and 4b). Suncheonosides A, B and D significantly promoted 
adipogenesis in hBM-MSCs by up to 107%, 65% and 75%, respectively, 
compared with the level observed in the IDX control. Suncheonoside C was 
likely to promote adipogenesis by up to 42%; however, the magnitude of 
this effect was above the statistical threshold (p = 0.05). To investigate the 
concentration dependency of the suncheonoside effect, the cell viability of 
hBM-MSCs was evaluated for the suncheonosides and their aglycone, 
which was obtained via enzymatic hydrolysis of suncheonoside A (Figure 
4c). A concentration-effect analysis of suncheonosides A, B and D and the 
aglycone of suncheonoside A (5) was performed at concentrations of up to 
100 mM because at this concentration, the compounds do not affect the 
viability of hBM-MSCs (Figure 4d). The adiponectin concentrations in the 
hBM-MSC culture media were measured by quantitative analysis (Figure 
4d). Glibenclamide was used as a positive control drug because adiponectin 
production during adipogenesis in hBM-MSCs can be used to evaluate anti-
diabetic drugs and improve insulin sensitivity.15 Glibenclamide increased 
adiponectin production in a concentration-dependent manner during 
adipogenesis in hBM-MSCs and exhibited a plateau in activity at 
concentrations above 10 mM. The suncheonosides promoted adiponectin 
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production during adipogenesis in hBM-MSCs in a concentration-dependent 
manner relative to the adiponectin production observed for the IDX control. 
However, compared with the maximum activity of glibenclamide, the 
maximum levels at which suncheonosides A, B and D promoted adiponectin 
production were 43.9%, 46.9% and 37.8%, respectively. Notably, the 
concentration effect of the suncheonosides decreased at 100 mM. In addition, 
the aglycone of suncheonoside A (5) did not promote adiponectin 
production in hBM-MSCs compared with that of the IDX medium control, 
suggesting that the L-rhamnose moiety is essential to the pharmacological 
activity of the suncheonosides. Although the direct molecular target of the 
pharmacological activity of the suncheonosides has not been identified, 
these benzothioate rhamnose glycosides may be used as a chemical tool to 
elucidate the corresponding pharmacological mechanism and thereby 
improve insulin sensitivity for a new class of anti-diabetic drugs.
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Figure 4. The effects of the suncheonosides on insulin sensitivity during 
adipogenesis in hBM-MSCs. (a) Adipogenesis of hBM-MSCs was induced 
by treating the adipocyte-differentiation-inducing medium supplemented 
with 10 mM of each suncheonoside in IDX medium. Suncheonosides A (1), 
B (2), and D (4) promoted adipogenesis by up to 107%, 65%, and 75%, 
respectively. (b) Differentiated adipocytes were visualized by co-staining 
with hematoxylin reagent on the ORO-stained adipocytes. (c) The hBM-
MSC cell viability effects of suncheonosides A, B, and D. (d) The 
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concentration-dependent effect of suncheonosides A, B, D, and the aglycone 
of suncheonoside A (5) on the production of adiponectin was evaluated 
during adipogenesis in hBM-MSCs. Values represent the mean expression ±
standard deviation (SD) (n = 3). * P ≤ 0.05 and ** P ≤ 0.01.
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II.1.2 Experimental section
General Experimental Procedures. Optical rotations were determined 
using a JASCO P-1020 polarimeter. UV spectra were measured on a 
PerkinElmer Lambda 35 UV/VIS spectrophotometer. IR spectra were 
recorded using a Thermo NICOLET iS10 spectrometer. 1H, 13C, and 2D 
NMR spectra were obtained on Bruker Avance 600 MHz spectrometers at 
the National Center for Inter-university Research Facilities at Seoul 
National University (NCIRF). Low-resolution electrospray ionization source 
mass spectra were acquired with an Agilent Technologies 6130 quadrupole 
mass spectrometer coupled to an Agilent Technologies 1200 series high-
performance liquid chromatography (HPLC) instrument. High-resolution fa
st-atom bombardment (HRFAB) mass spectra were obtained using a J
EOL JMS-600W high-resolution mass spectrometer at the NCIRF. 
Semi-preparative HPLC separations were achieved with a Gilson 305 pump 
and a Gilson UV/VIS-155 detector. 
Bacterial Isolation. A sediment sample was collected from Suncheon Bay, 
Republic of Korea, in 2013. Dried sediment was spread onto the surface of 
actinomycete isolation medium (1 L of seawater, 18 g of agar, 100 mg/L 
cycloheximide), A4 medium (1 L of seawater, 18 g of agar, 100 mg/L 
cycloheximide), A5 medium (750 mL of seawater, 250 mL of distilled water, 
18 g of agar, 100 mg/L cycloheximide), A6 medium (1 L of seawater, 18 g 
of agar, and 5 mg/L polymyxin B sulfate), A7 medium (1 L of seawater, 18 
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g of agar, and 5 mg/L kanamycin) and chitin-based agar plates using 
autoclaved foam plugs (2 cm in diameter). The plates were incubated at 
25 °C for 3 weeks. The strain SSC21 was isolated from an actinomycete 
isolation medium plate. Colonies were repeatedly inoculated onto fresh agar 
plates to obtain a pure culture. 16S rDNA sequencing of the strain SSC21 
was performed by COSMO Co., Ltd. A comparative sequence analysis 
indicated that strain SSC21 (GenBank accession number: KR007961) is 
most similar to Streptomyces pulveraceus (99% identity). 
Cultivation and Extraction. The strain SSC21 was initially cultivated in 
50 mL of modified K medium (2 g of yeast extract, 2 g of glucose, 3 g of 
mannitol, 5 g of starch, and 5 g of soytone in 1 L of distilled water). After 
the strain was cultivated for 5 days on a rotary shaker at 190 rpm and 30 °C, 
10 mL of the culture was inoculated in 1 L of modified K medium in a 2.8-L 
Fernbach flask. The entire culture (72 L) was extracted twice with ethyl 
acetate. The EtOAc extract was concentrated in vacuo to yield 7 g of dry 
material. 
Isolation of Suncheonosides A-D. One-half of the dried extract was 
fractionated with 150 mL each of 20%, 40%, 60%, 80%, and 100% MeOH 
in water using a packed C18 (20 g) column. After the fractionation, 
suncheonosides A-D (1-4) were found in the 20% and 40% MeOH/water 
fractions. Each fraction was then subjected to reversed-phase HPLC 
(Kromasil 100-5-C18 250 × 10 mm, flow rate 2 mL/min, UV 280 nm 
detection, 50%–60% aqueous acetonitrile gradient with 0.1% formic acid 
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over 60 min). Under these purification conditions, suncheonoside A (1) (7 
mg), suncheonoside B (2) (4 mg), suncheonoside C (3) (3 mg), and 
suncheonoside D (4) (7 mg) were purified with retention times of 25, 31, 30, 
and 20 min, respectively.
Suncheonoside A (1): white powder; +62 (c 0.5, MeOH); UV 
(MeOH) λmax (log ε) 206 (1.55) nm; IR (neat) νmax 3351, 2751, 1681, 1272, 
1038 cm-1; for 1H and 13C NMR data, Table 1; HRFABMS m/z 423.1043 
[M+Na]+ (calcd for C19H28O7NaS, 423.1055).
Suncheonoside B (2): white powder; +82 (c 0.3, MeOH); UV 
(MeOH) λmax (log ε) 207 (1.63) nm; IR (neat) νmax 3941, 3397, 2938, 1689, 
1342, 1130 cm-1; for 1H and 13C NMR data, Table 1; HRFABMS m/z
437.1712 [M+Na]+ (calcd for C20H30O7NaS, 437.1730).
Suncheonoside C (3): White powder; +72 (c 0.5, MeOH); UV 
(MeOH) λmax (log ε) 206 (1.62) nm; IR (neat) νmax 3261, 2849, 1646, 1630, 
1292, 1049 cm-1; for 1H and 13C NMR data, Table 1; HRFABMS m/z
437.1712 [M+Na]+ (calcd for C20H30O7NaS, 437.1730).
Suncheonoside D (4): White powder; +98 (c 0.3, MeOH); UV 
(MeOH) λmax (log ε) 209 (1.84) nm; IR (neat) νmax 3841, 3394, 2928, 1681, 
1442, 1208, 1040 cm-1; for 1H and 13C NMR data, Table 1; HRFABMS m/z
569.1843 [M+Na]+ (calcd for C25H38O11NaS, 569.1855).
Stereochemical analysis of rhamnose. Each of the suncheonosides A-D 
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(1-4) (2.0 mg quantity) was subjected to acid hydrolysis using 6 N HCl. 
Each hydrolysate was dissolved in pyridine (0.5 mL) containing L-cysteine 
methyl ester hydrochloride (0.5 mg) and heated to 60 °C for 1 h. One 
hundred microliters of a σ-tolyl isothiocyanate (0.5 mg) solution in pyridine 
(0.5 mL) was added to the mixture, which was then heated to 60 °C for 1 h. 
The reaction mixtures were directly analyzed using LC/MS (10%–100% 
aqueous acetonitrile gradient with 0.1% formic acid over 20 min). The 
hydrolysate derivatives of 1-4 were detected at 10.4, 10.6, 10.6, and 10.5 
min, respectively. The retention times of the authentic rhamnose samples 
were 10.4 (L-rhamnose) and 9.3 (D-rhamnose) min under the same LC/MS 
conditions. Therefore, the absolute configurations of the rhamnose units in 
1-4 were established as L-configurations.
Enzymatic hydrolysis. Suncheonoside A (1) (2.5 mg) was hydrolyzed in 
H2O (2 mL) with naringinase (30 mg, from Penicillium sp.; ICN 
Biomedicals Inc.) at 40 °C for 24 h. The reaction mixture was extracted with 
CHCl3. The CHCl3 layer was chromatographed over a normal-phase silica 
gel (Waters Sep-Pak Vac 6 cc) with a solvent composed of a 30:1 mixture of 
CHCl3-MeOH to yield the benzothioate aglycone (5, 1.5 mg) of 1.
Aglycone (5) of suncheonoside A (1): 1H NMR (600 MHz, pyridine-d5) δ
3.47 (m, 1H), 2.58 (s, 3H), 2.50 (s, 3H), 2.38 (s, 3H), 1.45 (d, J = 7.1, 3H), 
and 1.45 (d, J = 7.1, 3H); ESI-MS m/z 255 [M+H]+.
Computational Analysis. The ground-state geometries were optimized by 
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DFT calculations, using Turbomole 6.5 and the basis set def-SV(P) for all 
atoms at the B3LYP/DFT functional level; the ground states were further 
confirmed by harmonic frequency calculations.
Insulin sensitivity assay. The effect of the suncheonosides on insulin 
sensitivity was investigated in the adipogenesis model of hBM-MSCs as 
previously described.15 hBM-MSCs were purchased from Lonza, Inc. 
(Walkersville, MD, USA). hBM-MSCs were maintained in Dulbecco's
modified Eagle’s medium (DMEM) with low glucose (1 g/L glucose) 
containing 10% fetal bovine serum (FBS) (Lonza), supplemented with 
antibiotics and GlutamaxTM (Invitrogen, Carlsbad, CA, USA). When hBM-
MSCs were confluent in 24-well culture plates, adipogenesis was induced 
by exchanging the cell culture media with the adipocyte-differentiation-
inducing medium, i.e., DMEM with high glucose (4.5 g/L glucose) 
supplemented with 10% FBS, 10 mg/mL insulin, 1 mM dexamethasone, and 
0.5 mM 3-isobutyl-1-methylxanthine (IBMX) (IDX medium). After 
inducing adipogenesis in the hBM-MSCs, the IDX media were exchanged 
every 48 h. To evaluate cell viability, the hBM-MSCs were treated with 4-3-
[4-iodophenyl]-2-4(4-nitrophenyl)-2H-5-tetrazolio-1,3-benzene disulfonate 
(WST-1; 10 μM pure solution, Roche, Indianapolis, IN, USA) and further 
incubated for 2 h. The absorbances of the samples were determined at 450 
nm (A450). To measure the level of differentiated adipocytes in hBM-MSC 
culture, Oil Red O (ORO) staining was performed. Differentiated adipocytes 
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were washed in phosphate-buffered saline (PBS) and fixed for 30 minutes in 
10% formalin solution in PBS. Fixed cells were washed in 60% isopropyl 
alcohol and stained at room temperature with Oil Red O (ORO) in 60% 
isopropyl alcohol. After 5 minutes of ORO staining, the cells were quickly 
washed with distilled water. To determine the adipogenic level, adsorbed 
ORO was dissolved with 100% isopropyl alcohol, and the absorbance was 
measured at 500 nm. To stain the nuclei of differentiated adipocytes, 
hematoxylin reagent was counter-stained. The differentiated adipocytes in 
hBM-MSC culture were observed and imaged using an Olympus IX71 
inverted phase microscope (Olympus Co., Tokyo, Japan). To determine the 
concentrations of adiponectin in the cell culture supernatants of the hBM-
MSCs, adiponectin ELISA was performed according to the manufacturer’s 
instructions (R&D systems, Minneapolis, MN, USA).
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Table 1. NMR data for suncheonosides A-D (1-4) in pyridine-d5.
Suncheonoside A (1) Suncheonoside B (2) Suncheonoside C (3) Suncheonoside D (4)
Position dC, type dH, mult
(J in Hz)
dC, type dH, mult
(J in Hz)
dC, type dH, mult
(J in Hz)
dC, type dH, mult
(J in Hz)
1 127.5, C 132.0, C 131.6, C 131.6, C
2 152.4, C 154.8, C 152.8, C 153.1, C
2-OMe











140.7, C 141.6, C
6 120.5, C 127.2, C 125.1, C 127.0, C
7 197.3, C 196.7, C 197.0, C 197.5, C
8 11.4, CH3 2.58, s 11.0, CH3 2.31, s 11.2, CH3 2.31, s 11.9, CH3 2.54, s
9 14.2, CH3 2.48, s 14.5, CH3 2.38, s 13.5, CH3 2.38, s 12.8, CH3 2.38, s
10 32.1, CH 3.39, m 32.0, CH 3.31, m 32.9, CH 3.31, m 32.5, CH 3.32, m
11 21.7, CH3 1.38, d (7.0) 21.7, CH3 1.31, d (7.0) 21.6, CH3 1.31, d (7.0) 21.6, CH3 1.28, d (7.0)
12 21.6, CH3 1.41, d (7.0) 21.6, CH3 1.29, d (7.0) 21.5, CH3 1.29, d (7.0) 21.6, CH3 1.28, d (7.0)
13 12.8, CH3 2.41, s 12.7, CH3 2.47, s 12.3, CH3 2.47, s 14.6, CH3 2.37, s
2-L-rhamnose
1´ 107.2, CH 5.77, br s 107.2, CH 5.57, br s 107.3, CH 5.68, br s
2´ 72.3, CH 4.87, br s 72.2, CH 4.97, br s 72.2, CH 4.78, br s
3´ 72.8, CH 4.68, d (9.0) 72.8, CH 4.72, dd
(9.0, 3.0)
72.6, CH 4.62, dd
(9.0, 3.0)
4´ 73.4, CH 4.41, ddd
(9.0, 9.0, 3.5) 
73.4, CH 4.44, dd 
(9.0, 9.0)
73.4, CH 4.37, dd
(9.5, 9.0)
5´ 72.1, CH 4.62, dq 
(9.0, 6.0)









18.6, CH3 1.71, d (6.0) 18.7, CH3 1.66, d (5.0)
4-L-rhamnose
1″ 106.4, CH 5.56, br s 106.5, CH 5.54, br s
2″ 72.7, CH 4.96, br s 72.4, CH 4.98, br s
3″ 73.0, CH 4.67, dd
(9.0, 3.0)
72.7, CH 4.72, dd
(9.0, 3.0)
4″ 73.4, CH 4.43, t
(9.0, 9.0)
73.3, CH 4.44, dd
(9.0, 9.0)
5″ 72.4, CH 4.66, m 72.6, CH 4.68, m
6″ 18.7, CH3 1.72, d (6.0) 18.7, CH3 1.66, d (5.0)
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2. JS8 A and B, novel bacterial 
flavonoid, from Streptomyces sp. 
associated with white grub Protaetia 
brevitarsis seulensis.
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II .2.1. Results and discussion
JS8 A (6) was isolated as a as a colorless, non-crystalline solid. The 
molecular formula of 6 was assigned as C22H31NO8 based on HRFAB mass 
spectrometric data and 1H and 13C NMR data (Table 2). Comprehensive 
analysis of the COSY, HMQC and HMBC NMR spectra for 6 defined three 
substructures, a 2, 3, 6-trideoxyaminosugar, a 2-methyl-3-hydroxy-
butyramide, and an aglycone possessing a 5- hydroxymethyl-7, 8-
dihydroxyflavonoid structure. HMBC correlations were effective in 
providing the substitution pattern of the pentasubstituted aromatic ring and 
in connecting substructures. Correlations from the C-6 proton (dH 7.09) to 
the C-8 and C-10 carbons (dC 170.0 and 112.8 repectively), from the C-11 
methylene protons to the C-5, C-6 and C-10 carbons (dC 136.7, 105.8 and 
112.8) served to position free hydroxyl and hydroxymethyl substituents. The 
connection of the ketone fragment to the C-10 carbon (dC 112.8) was 
indicated by a correlation from the C-3b proton (dH 2.65). The C-3b proton 
also correlated with C-1', thus leading to placement of the CH2 substituent at 
C-2. The linkage of the glycoside at the C-7 hydroxyl was shown by the 
correlation of the anomerie proton (C-1", 5.80) to the C-7 carbon at dC 148.6. 
Furthermore, the sugar was confirmed to be in the pyranose by HMBC 
correlations from the anomeric proton to the C-5" carbon. Complete analysis 
of the NMR signals from the aminosugar led to its assignment as 
ristosamine. This was apparent from HMBC correlations from the C-3" 
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proton (dC 4.31) to the C-1"' amide carbonyl carbon (dC 169.5).(Figure 5)
Figure 5. Key 1H-1H COSY and HMBC correlations of 6.
JS8 B (7) was isolated as a as a colorless, non-crystalline solid as well as. 
The molecular formula of 7 was also assigned as C22H31NO8 based on 
HRFAB mass spectrometric data and 1H and 13C NMR data. The 13C NMR 
spectrum of 6, showed two sets of partially overlapping ABX spin systems. 
For example, the 13C NMR spectrum showed two methine carbon signals, at 
dC 94.0 and 94.1 which, on the basis of the formula for 6, could only 
account for one carbon. Production of a perbenzoate derivative, followed by 
chiral column HPLC analysis using UV detection illustrated conclusively 
that 6 was a 50/50 mixture of diastereomers. With the exception of the 
above, all other proton and carbon signals of the mixture appeared at 
identical chemical shifts JS8 compounds (6 and 7) was racemized at the 
only aglycone chiral carbon (C-2).
Complete analysis of the NMR signals from the aminosugar led to its 
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assignment as ristosamine, a rare deoxyamino sugar first observed as a 
component of the vancomycin-related antibiotic, ristomycin. The relative 
stereochemistry of the ristosamine moiety was determined by coupling
constant analysis. The magnitude of 1JCH (170 Hz) between C-1" and H-1"
was clearly indicative of an α-configuration.8 Complex couplings to the C-
3" proton rendered analysis difficult. However, the coupling constants for 
the C-4" proton were clear (3.5 and 10.0 Hz). Irradiation of the C-3" proton 
signal resulted in a simplified doublet, with J = 10 Hz, for the C-4" proton. 
Therefore, the 3.5 coupling constant placed the C-3", C-4" and C-5" protons 
in equatorial, axial and axial configurations, respectively.
To determine the absolute configuration of JS8 A (6), the modified 
Mosher’s method was applied.11 Prior to this procedure, the time-controlled 
acetylation of 6 mainly yielded a tri-acetate product (8) esterified at the C-1, 
C-8 and C-11. The secondary hydroxy group at C-2’ and C-4’’ in 6 was then 
derivatized with R-(-) and S-(+)-α-methoxy-α-(trifluoromethyl)phenylacetyl 
chloride (MTPA-Cl) to yield the S- and R- MTPA esters (9 and 10), 
respectively. The 1H chemical shifts of the relevant protons were assigned 
by analyzing the 1H NMR spectra of 9 and 10. Calculating the ΔδS-R values
established the absolute configuration of 2S. (Figure 6). 
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Figure 6. Stereochemical determination of the JS8 A (6) (application of 
time controlled acetylation and Modified mosher method).
Based on the absolute configuration of JS8 A and B, the assignment was 
further confirmed by comparing the experimental ECD spectrum of 
hydrosylate of JS8 A (6) and the calculated ECD spectra of the hydrosylate 
of JS8 A (12). The experimental ECD spectrum of 12 displayed positive 
Cotton effects at 220 and 290 nm, which is consistent with the calculated 
ECD spectrum of the 2S (Figure 7a) and the experimental ECD spectrum of 
13 displayed negative Cotton effects at 220 and 290 nm, which is consistent 
with the calculated ECD spectrum of the 2R (Figure 7b). Therefore, the 
absolute configuration of JS8 A was established as 2S and the absolute 
configuration of JS8 B as 2R (Figure 7).
Figure 7. (a) Experimental CD spectra of hydrosylate of 11 and
calculated ECD spectra of hydrosylate of 11. (b) Experimental CD spectra 
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of hydrosylate of 12 and calculated ECD spectra of hydrosylate of 12.
JS8 A and B are biosynthetically interesting because they are unusual 
bacterial metabolites. The only reported bacterial flavonoid producer is the 
strain CNB-689 which produces actinoflavoside (13). The comparative 
whole genome sequence analysis of the strain JS8 and the CNB-689 was 
conducted to find out the biosynthetic pathway of bacterial flavonoid. At 
first, we performed stable isotope labeling experiments to distinguish 
between the chalcone synthase (CHS) using 4-coumaroyl-CoA with three 
malonyl-CoA and aloesone synthase (ALS) using acetyl-CoA with six 
malonyl-CoA. The [2-13C]sodium acetate was provided as a precursor to the 
JS8 A and 13C NMR analysis of labeled sodium acetate-enriched JS8 A 
revealed the specific isotopic labeling of C11 at approximately 20% 
enrichment (Figure S14). And to confirm the incorporation of an isovaleryl-
CoA as a starting unit, [1-13C]sodium acetate was also labeled (Figure S15). 
As a result, the specific isotopic labeling of C2 and C3 were founded we 
could conclude isovaleryl-CoA is used as a starting unit. Moreover, due to 
the ALS pathway was traced by injection of stable isotope L-leucine 
(precursor of isovaleryl-CoA), the isotopically labeled products were 
analyzed by LC/MS and the product profiles formed in the presence of 
isovaleryl-CoA. The comparative whole genome sequence analysis of the 
strains JS8 and CNB-689 identified common putative gene clusters for 
bacterial flavonoid biosynthesis. Stable isotope labeling experiments using 
[1-13C]sodium acetate, [2-13C]sodium acetate, universally-labeled leucine 
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revealed that JS8A and B were produced through a biosynthetic pathway 
analogous to that for aloesone-type flavonoids in plants (Figure 8). 
Figure 8. Proposed biosynthetic pathway of JS8 A.
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II.2.2. Experimental section
General Experimental Procedures. Optical rotations were measured on a 
JASCO P1020 polarimeter with a 1 cm cell. UV spectra were acquired with
a PerkinElmer Lambda 35 UV/VIS spectrophotometer and ECD spectra 
were recorded using an Applied Photopysics Chirascan-Plus circular 
dichroism spectrometer. IR spectra were recorded using a Thermo 
NICOLET iS10 spectrometer. 1H, 13C, and 2D NMR spectra were obtained 
on a Bruker Avance 850 MHz spectrometer at the the National Center for 
Inter-University Research Facilities (NCIRF) at Seoul National University. 
1H and 13C NMR chemical shifts (dH and dC) were recorded in ppm. Low-
resolution electrospray ionization source mass spectra were acquired with an 
Agilent Technologies 6130 quadrupole mass spectrometer coupled to an 
Agilent Technologies 1200 series high-performance liquid chromatography 
(HPLC) instrument. High-resolution electrospray ionization mass spectra 
(HRESIMS) were obtained using a Thermo Scientific Q high-resolution 
mass spectrometer at the NICEM (National Instrumentation Center for 
Environmental Management at Seoul National University). Semi-
preparative HPLC separations achieved with a Gilson 305 pump and a 
Gilson UV/VIS 155 detector.
Isolation and Classification of a bacterial strain JS8. The bacterical 
strain JS8 was isolated from the gut of a Protaetia brevitarsis seulensis grub. 
A white grub specimen was washed with sterilized water and then soaked in 
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97% ethanol to remove the microbes on their exoskeleton. Only abdomen 
was extracted using a razor blade and the cuticle of the abdomen was 
removed. The intestinal parts were placed in a conical tube containing 20 
mL of sterilized distilled water at 25 °C. The tube was vortexed, and 300-μL 
aliquots of the suspension were spread onto the surfaces of actinomycete 
isolation medium (1 L of distilled water, 22 g of actinomycete isolation 
medium, 18 g of agar, and 100 mg/L cycloheximide), A4 medium (1 L of 
distilled water, 18 g of agar, and 100 mg/L cycloheximide), A6 medium (1 L 
of distilled water, 18 g of agar, and 5 mg/L polymyxin B sulfate), A7 
medium (1 L of distilled water, 18 g of agar, and 5 mg/L kanamycin) and 
chitin-based agar medium (1 L of distilled water, 4 g of chitin, 18 g of agar, 
and 100 mg/L cycloheximide) plates using autoclaved foam plugs (2 cm in 
diameter) and spreaders. The plates were incubated at 25 °C for 3 weeks. 
Strain JS8 was isolated from a actinomycete isolation medium plate. 
Colonies were repeatedly inoculated onto fresh YEME agar (1 L of distilled 
water, 18 g of agar, 4 g of yeast extract, 4 g of glucose, and 10 g of malt 
extract) plates to obtain a pure culture.
Cultivation and Isolation. The strain was cultivated in 50 mL of modified 
K medium (2 g of yeast, 2 g of glucose, 3 g of mannitol, 5 g of soytone, 5 g 
of starch and 1 g of calcium carbonate in 1 L of distilled H2O). After 
culturing the strain for 5 days on a rotary shaker at 190 rpm and 30 °C, 10 
mL of the culture was inoculated into 1 L of modified K medium in a 2.8 L 
Fernbach flask. The entire culture (24 L) was extracted twice with EtOAc 
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then concentrated in vacuo to yield 30 g of dry material. After extraction, 
the extract was directly subjected to reversed-phase high-performance liquid 
chromatography (HPLC; Kromasil 100-5-C18 250 × 10 mm, flow rate 2 
mL/min, UV 280 nm detection, 58% aqueous MeOH isocratic). Under these 
purification conditions, JS8 A (1) and B (2) were purified together with 
retention times of 32 min. For further purification, two epimeric compounds 
were isolated by normal-phase high-performance liquid chromatography 
(HPLC; CTK Chiralpak IB 250 × 4.6 mm, flow rate 1 mL/min, UV 280 nm 
detection, n-Hexane/Ethanol = 80/20 isocratic). Finally, JS8 A (1, 12 mg) 
and JS8 B (2, 12 mg) were isolated as pure compounds as retention times of 
16 min and 20 min, respectively.
JS8 A (6): Colorless, non-crystalline solid; [α]25D -45.0 (c 0.5, MeOH); UV 
(MeOH) λmax (log ε) 261 (2.46) nm; ECD (c 4.3 × 10
−4 M, MeOH) λmax (Δε) 
220 (10.4), 312 (1.6) nm; IR (neat) νmax 3360, 1660 cm
-1; 1H and 13C NMR 
data in Table 2; ESI MS m/z 436.1756 [M-H]- (calcd for C22H30NO8, m/z
436.1753).
JS8 B (7): Colorless, non-crystalline solid; [α]25D -80.0 (c 0.1, MeOH); UV 
(MeOH) λmax (log ε) 255 (2.13) nm; ECD (c 4.3 × 10
−4 M, MeOH) λmax (Δε) 
248 (3.12), 330 (1.36) nm; IR (neat) νmax 3300, 1580
-1; ESI MS m/z
436.1756 [M-H]- (C22H30NO8, m/z 436.1753).
Acetylation of 6. JS8 A (6, 4 mg) was dissolved in pyridine (2 mL), and a 
stock solution of acetic anhydride was prepared in pyridine (0.42 mM: 80 mL 
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acetic anhydride in 2 mL pyridine). The stock solution was added to the JS8 
A solution gradually in 10 or 20 mL aliquots, and the reaction was monitored 
by liquid chromatography/mass spectrometry (LC/MS). The reaction 
solution was cooled when the acetic anhydride solution was added, and the 
mixture was stirred at room temperature. When 400 mL of the stock solution
in total had been applied for 9 h. The reaction was halted by adding 10 mL of 
water. The acetate of JS8 A (3, 3.4 mg) was purified through reversed-phase 
HPLC (Kromasil 100-5-C18 250 × 10 mm, flow rate 2 mL/min, UV 280 nm 
detection, 75% aqueous MeOH isocratic, retention time 20 min). The 
molecular formula (C28H39NO12) of the desired product, an acetate of JS8 A 
(3), was confirmed by electrospray mass spectrometry (ESI MS) ([M+H]+
m/z at 581) and 1H NMR data spectroscopy.
Acetate (8) of JS8 A (6): 1H NMR (600 MHz, CD3OD) δ 6.17 (br s, 1H), 
5.75 (dd, J = 17.5, 10.5, 1H), 4.89 (dd, J = 17.5, 1.0, 1H), 4.85 (dd, J = 10.5, 
1.0, 1H), 4.75 (m , 2H), 4.28 (s, 1H), 3.42 (m, 1H), 2.78 (dd, J = 18.0, 4.5, 
1H), 2.71 (m, 2H), 2.61 (dd, J = 18.0, 14.0, 1H), 2.46 (d, J = 18.0, 1H), 2.19 
(s, 3H), 1.91 (d, J = 18.0, 1H), 1.52 (m, 2H), 1.02 (s, 3H), and 0.98 (s, 3H). 
MTPA Esterification of JS8 A Acetate (8). Acetate (8) was prepared in 
two 40 mL vials (two 1.7 mg samples), which were dried completely under 
high vacuum for 12 h. First, freshly distilled anhydrous pyridine (1 mL) was 
prepared prior to the addition of a catalytic amount of 
dimethylaminopyridine to the solution. R-(-) and S-(+)-MTPA chloride (10 
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mL) were added separately and the mixture stirred at room temperature. 
After 3 h, the reaction was quenched with 0.5 mL of MeOH. The products 
were then purified using reversed-phase HPLC (Kromasil 100-5-C18 250 ×
10 mm, flow rate 2 mL/min, UV 280 nm detection) under gradient 
conditions ranging from 60% to 100% aqueous acetonitrile. The S-MTPA 
(9) and R-MTPA (10) esters eluted at 27.0 and 27.5 min, respectively. The 
molecular formulae (C48H53F6NO16) of the MTPA esters were confirmed by 
ESI MS ([M+H]+ m/z at 1014) and 1H NMR spectroscopy. The 1H chemical 
shifts around the stereogenic centers of the derivatives were assigned by 1H 
NMR spectra of 9 and 10.             
S-MTPA ester (9) of acetate (8): 1H NMR (600 MHz, DMSO-d6) δ 7.25-
7.15 (m, 5H), 6.10 (br s, 1H), 5.75 (dd, J = 17.5, 10.5, 1H), 5.18 (s, 1H), 
4.74 (dd, J = 17.5, 1.0, 1H), 4.70 (dd, J = 10.5, 1.0, 1H), 4.60 (m , 2H), 3.49 
(s, 3H), 3.46 (m, 1H), 2.74 (dd, J = 18.0, 4.5, 1H), 2.71 (m, 2H), 2.63 (dd, J 
= 18.0, 14.0, 1H), 2.46 (d, J = 18.0, 1H), 2.19 (s, 3H), 1.91 (d, J = 18.0, 1H), 
1.52 (m, 2H), 1.01 (s, 3H), and 0.95 (s, 3H). 
R-MTPA ester (10) of acetate (8): 1H NMR (600 MHz, DMSO-d6) δ
7.26-7.10 (m, 5H), 6.08 (br s, 1H), 5.72 (dd, J = 17.5, 10.5, 1H), 5.21 (s, 
1H), 4.76 (dd, J = 17.5, 1.0, 1H), 4.72 (dd, J = 10.5, 1.0, 1H), 4.62 (m , 2H), 
3.49 (s, 3H), 3.45 (m, 1H), 2.75 (dd, J = 18.0, 4.5, 1H), 2.72 (m, 2H), 2.64 
(dd, J = 18.0, 14.0, 1H), 2.47 (d, J = 18.0, 1H), 2.18 (s, 3H), 1.89 (d, J = 
18.0, 1H), 1.50 (m, 2H), 1.02 (s, 3H), and 0.97 (s, 3H). 
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Computational Analysis. The ground-state geometries were optimized by 
DFT calculations using Turbomole 6.5 with the basis set def-SV(P) for all 
atoms at the functional B3LYP/DFT level. The ground states were further 
confirmed by harmonic frequency calculations. The calculated ECD data 
corresponding to the optimized structures were obtained with TD-DFT at 
the functional B3LYP/DFT level at the basis set def2-TZVPP for all atoms. 
The CD spectra were simulated by overlapping each transition, where σ is 
the width of the band at 1/e height. ΔEi and Ri are the excitation energies and 
rotatory strengths for transition i, respectively. In the current work, the value 
of σ was 0.10 eV.
Measurment of labeles precursor incorporation rate using [2-
13C]sodium acetate and [1-13C]sodium acetate. [2-13C]sodium acetate and 
[1-13C]sodium acetate were purchased from Sigma Aldrich Korea. [2-
13C]sodium acetate (1.0 g/l) was added to the JS8 strain liquid culture. JS8 A 
and B labled with [2-13C]sodium acetate were purified via reversed-phase 
HPLC (Kromasil 100-5-C18 250 × 10 mm, flow rate 2 mL/min, UV 280 nm 
detection) using an isocratic of 58% aqueous methanol. And for further 
purification, JS8 A and B were isolated by normal-phase high-performance 
liquid chromatography (HPLC; CTK Chiralpak IB 250 × 4.6 mm, flow rate 
1 mL/min, UV 280 nm detection, n-Hexane/Ethanol = 80/20 isocratic). JS8 
A and B were eluted at 16 and 19 min, respectively. Also, [1-13C]sodium 
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acetate (1.0 g/l) was added to the JS8 strain liquid culture and JS8 A and B 
labled with [1-13C]sodium acetate. After purification labeled JS8 A and B 
were assigned by 1H NMR spectra and incoportation ratio were calculated.
Measurment of labeles precursor of universally-labeled leucine
Universally-labele leucine (L-Leucine-13C6,
15N) from Sigma Aldirch Korea 
was feeding with liquid culture of JS8 strain. The isotopically labeled 
products were analyzed by liquid chromatography/mass spectrometry 
(LC/MS) under a gradient solvent system (flow rate: 0.7 mL/min; UV 
detection: 210, 230, 254, 280, and 360 nm; 10% to 100% aqueous 
acetonitrile [CH3CN/H2O] with 0.1% formic acid over 20 min).
44
Table 2. NMR data for JS8 (6) in DMSO-d6.
a 1H and 13C NMR were recorded at 850 and 212.5 MHz, respectively.
Position dC, type dH, mult (J in Hz)
2 75.7, CH 4.51, m
3 43.8, CH2 2.65, dd (16.5, 11.0)
2.6, dd (16.5, 5.4)
4 192.7, C
5 136.7, C







11 61.6, CH2 4.74, d (4.0)



















3.29, dd (10.0, 3.5)
5´´ 66.2, CH 3.71, dq (16.5, 10.0)
6´´ 17.8, CH3 1.06, d (6.3)
1´´´ 169.5, C









3. Actinomadurol, an antibacterial 
norditerpenoid from a rare 
actinomycete, Actinomadura sp. KC-
191
46
II.3.1. Results and discussion
Actinomadurol (13) was isolated as a colorless oil yielding an [M-H]- ion 
at m/z 317.1756 in its high-resolution electrospray ionization mass spectrum 
(HRESIMS). The exact mass was consistent with the molecular formula 
C19H26O4 while the molecular formula provided seven unsaturation 
equivalents. The infrared (IR) absorption peaks at 3360 and 1660 cm-1
indicated the presence of hydroxy and carbonyl functional groups, 
respectively. The 13C NMR spectrum revealed the presence of 19 carbon 
signals, which were classified by the DEPT spectrum as two sp3 methyls (δC 
24.3 and 12.6), five sp3 methylenes (δC 63.2, 41.2, 35.1 29.3, and 25.9), 
three sp3 methines (δC 82.1, 68.6, and 40.3), two sp
3 quaternary carbons (δC 
49.0 and 35.4), one sp2 methylene (δC 110.3), two sp
2 methines (δC 149.8 
and 121.3), three fully substituted sp2 carbons (δC 169.5, 140.1, and 129.3), 
and one carbonyl carbon (δC 201.4). Three double bonds (six olefinic sp
2
carbons) and one carbonyl group accounted for four unsaturations thereby 
suggesting that actinomadurol (13) contains three rings in its structure.  
The 1JCH direct connectivities between protons and carbons were 
established by analyzing the HSQC spectrum and the tabulated 1H and 13C 
NMR spectral data for 13, which are listed in Table 4. The planar structure 
of actinomadurol (13) was elucidated by analyzing COSY and HMBC 
spectra (Figure 9). The COSY correlations between the olefinic H-15 (δH 
5.83) and H2-16 (δH 4.94 and 4.83) peaks revealed the existence of a 
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terminal methylene. Two methylenes were shown to be connected by 1H-1H 
coupling between H2-11 (δH 2.54 and 2.34) and H2-12 (δH 1.47 and 1.38) 
signals in the COSY spectrum. The 1H-13C long-range couplings from the 
H3-17 (δH 1.02) singlet to the quaternary C-13 (δC 35.4) signal, C-12 (δC 
35.1) and the C-14 (δC 41.2) methylene resonances, and the olefinic C-15 
(δC 149.8) peak established the connectivities of C-11 through to C-17. A 4-
methyl-4-vinylcyclohex-1-ene moiety was constructed by the HMBC 
correlations from the H2-14 (δH 2.22 and 1.91) signals to the C-8 (δC 129.3) 
and C-9 (δC 140.1) resonances and from the H2-12 peak to the C-9 signal. 
Figure 9. Key 1H-1H COSY and HMBC correlations of 13.
Correlations between the peaks of the methine H-5 (δH 3.13) and 
methylene H2-6 (δH 1.99 and 1.87) were observed in the COSY spectrum, 
connecting C-5 and C-6. Another cyclohexene partial structure was 
elucidated based on the HMBC couplings from the H3-18 (δH 0.86) singlet
to an oxymethine C-1 (δC 82.1), a quaternary C-10 (δC 49.0), and olefinic C-
9 (δC 140.1) and a methine C-5 (δC 40.3) and from the H-6 resonance to C-7 
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(δC 68.6) and C-8.
The hydroxymethyl H2-19 peaks (δH 4.31 and 4.26) displayed 
2JCH and 
3JCH correlations to the olefinic fully substituted C-4 (δC 169.5), the olefinic 
methine C-3 (δC 121.3), and the aliphatic methine C-5 (δC 40.3) signals. The 
HMBC correlations between the signals of H-3 (δH 6.35) and C-1 and 
between the resonances of the oxymethine H-1 (δH 4.28) and the ketone C-2 
(δC 201.4) established the presence of the last six-membered ring moiety. 
Consequently, the structure of actinomadurol (13) was determined as a new 
C-19 norditerpenoid that is structurally similar to the pimarane class. 
JBIR-65 (14) was obtained as a major secondary metabolite during the 
purification of actinomadurol (1). 1H and 13C NMR spectra of 14 exhibited 
analogous features to those of 13. The structure of JBIR-65 (2) was 
confirmed as a previously reported secondary metabolite by comparison of 
the NMR data (Table S1) with the literature.25 The original source of the 
compound was a sponge associated Actinomadura strain.25
The relative configuration of actinomadurol (13) was determined by 
analyzing 1H-1H coupling constants and NOESY NMR correlations (Figure 
10). The H-5 signal (dd, J = 13.5, 2.0 Hz) showed a large coupling with the 
H-6b peak (ddd, J = 13.5, 13.5, 4.0), clearly indicating their pseudo-axial 
positions. The H-1/H-5 NOESY correlation revealed that H-1 is located in a 
pseudo-axial position. The carbinol H-7 peak possesses only small coupling 
constants (dd, J = 4.0, 2.0), indicating its pseudo-equatorial position. The H-
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11a signal showed a strong 1,3-NOESY correlation with the H3-17 peak, 
whereas H-11b displayed a clear NOESY correlation with the H3-18 
resonance, revealing that the C-17 and C-18 methyl groups exist pseudo-
axially on opposite faces. Thus, the relative configuration of 13 was 
determined to be 1S*, 5R*, 7R*, 10S*, and 13R*.
Figure 10. The strong NOESY correlations observed in 13.
The relative configuration of JBIR-65 (14), which is the 6-oxo-form of 13, 
has not been previously reported. Consequently, its configuration was 
analyzed using 1H-1H coupling constants and NOESY correlations, as for 13. 
However, for compound 14, I could not determine the configuration of C-13
because of the overlapping signals of the two methylenes at H2-11 and H2-
12, even in the 900 MHz 1H NMR spectrum (Table S1 and Figure S8). 
Eventually, I obtained two possible relative configurations (1S*, 5R*, 10S*, 
and 13R*; 1S*, 5R*, 10S*, and 13S*).













Mosher’s method was applied.26 Prior to this procedure, the time-controlled 
acetylation of 13 mainly yielded a mono-acetate product (15) esterified at 
the primary alcohol at C-19. The secondary hydroxy group at C-1 in 13 was 
then derivatized with R-(-) and S-(+)-α-methoxy-α-
(trifluoromethyl)phenylacetyl chloride (MTPA-Cl) to yield the S- and R-
MTPA esters (16 and 17), respectively. The 1H chemical shifts of the 
relevant protons were assigned by analyzing the 1H NMR spectra of 16 and 











4: R = (S)-MTPA
5: R = (R)-MTPA
Figure 11. ΔδS-R values in ppm of 16 and 17 in DMSO-d6.
Although the C-5 and C-10 stereogenic centers in 14 were determined as 
5R and 10S, respectively, based on the relative configuration of the left ring 
of 14, the absolute configuration of C-13 could not be assigned: the relative 
configuration of this center was not established because of the overlapping 
1H NMR resonances of H-11a/H-11b and H-12a/H-12b (Table S1). 
Therefore, I determined the last stereogenic center by calculating the 
electronic circular dichroism (ECD) spectra of the two possible 
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configurations (1S, 5R, 10S, and 13R; 1S, 5R, 10S, and 13S).27 These spectra 
were calculated using time-dependent density-functional theory (TD-DFT) 
at the B3LYP/def2-TZVPP//B3LYP/def-SV(P) level for all atoms. The 
experimental ECD spectrum of 14 showed a negative Cotton effect at 248 
nm, which corresponded better to the calculated ECD spectrum for the 1S, 
5R, 10S and 13R configuration than to that of the 13S configuration (Figure 
S17). Therefore, the absolute configuration of 14 was finally assigned as 1S, 
5R, 10S and 13R.
Based on the absolute configuration of 14, actinomadurol (13), which 
shares a common biosynthetic origin with 14, presumably possesses a 1S, 
5R, 7R, 10S, and 13R configuration. This assignment was further confirmed 
by comparing the experimental ECD spectrum of 13 and the calculated ECD 
spectra of the two possible enantiomers of 13. The experimental ECD 
spectrum of 13 displayed positive Cotton effects at 220 and 310 nm, which 
is consistent with the calculated ECD spectrum of the 1S, 5R, 7R, 10S, and 
13R configuration, whereas its enantiomer (1R, 5S, 7S, 10R, and 13S) 
showed an opposite calculated ECD spectrum (Figure S18). Therefore, the 
absolute configuration of actinomadurol (13) was established as 1S, 5R, 7R, 
10S, and 13R.  
Because the extract of Actinomadura strain KC 191 showed significant 
antibacterial activity, the biological activities of actinomadurol (13) and
JBIR-65 (14) were evaluated against diverse pathogenic bacteria. As 
previously reported,25 JBIR-65 did not display any antibacterial activity 
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(MIC > 100 mg/mL) in our tests. However, actinomadurol exhibited 
significant inhibitory activities comparable to or even stronger than those of 
the positive control ampicillin against Staphylococcus aureus, Bacillus 
subtilis, Kocuria rhizophila, Proteus hauseri, and Salmonella enterica (MIC 
= 0.39 ~ 3.12 mg/mL), but not against Escherichia coli (MIC > 100 mg/mL) 
(Table 3). Based on the antibacterial assay result the reduction of a ketone 
functional group (14) to a secondary alcohol (13) at C-7 was apparently the 
cause of the significant antibacterial activity. An attempt to reduce the 
ketones at C-2 and C-7 in JBIR-65 (14) with NaBH4 to produce 
actinomadurol analogues with secondary alcohols at C-2/C-7 was 
unsuccessful because JBIR-65 was degraded during reduction.
Further biological evaluations of 13 and 14 using cytotoxicity assays 
against various cancer cell lines (A549, HCT116, SNU638, SK-HEP1, 
MDA-MB231 and K562) were performed. Compounds 13 and 14 did not 
inhibit the growth of the tested cancer cell lines, even at high concentrations 
(IC50 > 100 mg/mL). In addition, the two compounds did not display any 
inhibitory activity against Candida albicans, Aspergillus fumigatus, 
Trichophyton rubrum, Trichophyton mentagrophytes (MIC > 100 mg/mL) as 
well as against Candida albicans-derived isocitrate lyase (ICL), a key 
enzyme in microbial biosynthesis.28
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Table 3. Antibacterial activities of Actinomadurol (13) and JBIR-65 (14)
Antibacterial activity (MIC, mg/mL)
S. aureus B. subtilis K. rhizophila P. hauseri S. enterica E. coli
1 0.78 1.56 0.39 0.78 3.12 >100
2 >100 >100 >100 >100 >100 >100
Ampicillin 3.12 1.56 0.79 1.56 3.12 6.25
Bacterial diterpenoids have been reported only rarely since the discovery 
of the first examples, the gibberellins from Rhizobium phaseoli in 1988,29
and most of these compounds were discovered from streptomycete 
actinobacteria.30 Diterpenoids have been even more infrequently isolated 
from rare actinobacteria. Brasilicardins A-D, tricyclic diterpenoids with 
cytotoxic and immunosuppressive activities, were isolated from Nocardia 
brasiliensis31 while tuberculosinol and the isotuberculosinols, which play 
key roles in pathogenesis, were isolated from Mycobacterium tuberculosis.32
Another rare actinobacterium, Verrucosispora gifhornesis, produced the 
gifhornenolones, which are norditerpenoids with potent inhibitory activity 
against the androgen receptor.33 In turn, actinomadurol (13) and JBIR-65 
(14) are rare members of the bacterial norditerpenoid metabolite series. To 
the best of our knowledge, aside from the gifhornenolones, only two similar 
series of bacterial norditerpenoids have been reported as C-16 
norditerpenoid antibiotics, namely the platensimycins34 and the platenicins35
from Streptomyces platenesis strains.
In summary, our chemical investigation of Actinomadura sp. KC 191 
revealed a new antibacterial secondary metabolite, actinomadurol (13), and 
the absolute configuration of JBIR-65 (14). The potent antibacterial activity 
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of 13 and its unique 19-norditerpenoid carbon backbone provide a new 
scaffold for antibiotic discovery. The discovery of this rare diterpenoid from 
the relatively uninvestigated actinobacterial genus Actinomadura underpins




General Experimental Procedures. Optical rotations were determined 
with a JASCO P1020 polarimeter using a 1 cm cell. UV spectra were 
measured on a PerkinElmer Lambda 35 UV/VIS spectrophotometer and 
ECD spectra were recorded using an Applied Photopysics Chirascan-Plus 
circular dichroism spectrometer. IR spectra were recorded using a Thermo 
NICOLET iS10 spectrometer. 1H, 13C, and 2D NMR spectra were obtained 
on a Bruker Avance 900 MHz spectrometer at the Korea Basic Science 
Institute (KBSI) in Ochang. 1H and 13C NMR chemical shifts (dH and dC) 
were recorded in ppm. Low-resolution electrospray ionization source mass 
spectra were acquired with an Agilent Technologies 6130 quadrupole mass 
spectrometer coupled to an Agilent Technologies 1200 series high-
performance liquid chromatography (HPLC) instrument.  High-resolution 
electrospray ionization mass spectra (HRESIMS) were obtained using a 
Thermo Scientific Q high-resolution mass spectrometer at the NICEM 
(National Instrumentation Center for Environmental Management at Seoul 
National University). Semi-preparative HPLC separations achieved with a 
Gilson 305 pump and a Gilson UV/VIS 155 detector.
Isolation and Classification of an Actinobacterial strain KC 191.
Strain KC 191 was isolated from a soil sample taken from Palace Leas hay 
meadow plot 6 at Cockle Park Experimental Farm, Northumberland, UK 
(National Grid Reference NZ 202912) using starch-casein agar,36
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supplemented with cycloheximide and nystatin (at 25 μg/mL), a medium 
known to favor the selective isolation of streptomycetes.37 Biomass for the 
comparative 16S rRNA gene sequence analyses was grown in shake flasks 
of glucose-yeast extract-malt extract broth (ISP medium 2) at 28 °C for 7 
days, harvested by centrifugation and washed twice in distilled water.37
Genomic DNA was extracted from the resultant biomass, and polymerase
chain reaction (PCR) amplification and 16S rRNA gene sequencing 
achieved using previously described procedures.38 The nearly complete 16S 
rRNA gene sequence (1392 nucleotides [nt]) of strain KC 191 was aligned 
manually against corresponding sequences of representatives of the genus 
Actinomadura using MEGA 5.0 software (MEGA software, Philadelphia, 
PA, USA)39  and  phylogenetic trees inferred by using the neighbor-
joining,40 maximum-likelihood41 and maximum-parsimony.42 The Jukes & 
Cantor model43 was used to generate evolutionary distance matrices for the 
neighbor-joining data. The resultant tree topologies were evaluated by 
bootstrap analysis44 based on 1000 resampled datasets using MEGA 5.0. 
The strain shared a phyletic line within a subclade which also encompassed 
the type strains of Actinomadura glauciflava, Actinomadura 
masheskhailensis and Actinomadura mexicana, a relationship that was 
supported by all of the tree-making algorithms and by a high bootstrap value 
(Figure S19). The strain was most closely related to A. mexicana A290T, 
these strains shared a 16S rRNA gene sequence similarity of 99.6%, a value 
which corresponded to 6 nucleotide differences at 1386 locations. 
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Consequently, strain KC 191 (GenBank accession number KU936908) 
forms the nucleus of a potentially novel species within the genus 
Actinomadura. 
Cultivation and Isolation. The strain was cultivated in 50 mL of yeast 
extract-malt extract (YEME) medium (4 g of yeast, 4 g of glucose, and 10 g 
of malt in 1 L of distilled H2O). After culturing the strain for 7 days on a 
rotary shaker at 190 rpm and 30 °C, 10 mL of the culture was inoculated 
into 1 L of YEME medium in a 2.8 L Fernbach flask. The entire culture (80 
L) was extracted twice with EtOAc then concentrated in vacuo to yield 5 g 
of dry material. After extraction, the extract was fractionated by C18
reversed-phase vacuum flash chromatography using a sequential mixture of 
MeOH and H2O as the eluent (five fractions eluted with a MeOH/H2O 
gradient from 20% to 100%). After fractionation, compounds 1 and 2 were 
found in the 60% and 80% MeOH/H2O fractions. Each fraction was then 
subjected to reversed-phase high-performance liquid chromatography 
(HPLC; Kromasil 100-5-C18 250 × 10 mm, flow rate 2 mL/min, UV 254 nm 
detection, 68% aqueous MeOH isocratic). Under these purification 
conditions, actinomadurol (1) and JBIR-65 (2)10 were purified with 
retention times of 30 and 25 min, respectively.
Actinomadurol (13): Colorless oil; [α]25D -45.0 (c 0.5, MeOH); UV 
(MeOH) λmax (log ε) 261 (2.46) nm; ECD (c 4.3 × 10
−4 M, MeOH) λmax (Δε) 
220 (10.4), 312 (1.6) nm; IR (neat) νmax 3360, 1660 cm
-1; 1H and 13C NMR 
data in Table 4; ESI MS m/z 317.1756 [M-H]- (calcd for C19H25O4, m/z
58
317.1753).
JBIR-65 (14): Colorless oil; [α]25D -80.0 (c 0.1, MeOH); UV (MeOH) λmax 
(log ε) 255 (2.13) nm; ECD (c 4.3 × 10−4 M, MeOH) λmax (Δε) 248 (3.12), 
330 (1.36) nm; IR (neat) νmax 3300, 1580
-1; ESI MS m/z 317.1753 [M+H]+
(calcd for C19H25O4, m/z 317.1736).
Acetylation of 14. JBIR-65 (14, 4 mg) was dissolved in pyridine (2 mL), 
and a stock solution of acetic anhydride was prepared in pyridine (0.42 mM: 
80 mL acetic anhydride in 2 mL pyridine). The stock solution was added to 
the JBIR-65 solution gradually in 10 or 20 mL aliquots, and the reaction was 
monitored by liquid chromatography/mass spectrometry (LC/MS). The 
reaction solution was cooled when the acetic anhydride solution was added, 
and the mixture was stirred at room temperature. When 400 mL of the stock 
solution in total had been applied for 7 h, the reaction yielded 85% of the 
mono-acetate (15) of JBIR-65. The reaction was halted by adding 10 mL of 
water. The acetate of JBIR-65 (15, 3.4 mg) was purified through reversed-
phase HPLC (Kromasil 100-5-C18 250 × 10 mm, flow rate 2 mL/min, UV 
254 nm detection, 75% aqueous MeOH isocratic, retention time 20 min). 
The molecular formula (C21H26O5) of the desired product, an acetate of 
JBIR-65 (3), was confirmed by electrospray mass spectrometry (ESI MS) 
([M+H]+ m/z at 359) and 1H NMR data spectroscopy.
Acetate (15) of JBIR-65 (14): 1H NMR (600 MHz, CD3OD) δ 6.17 (br s, 
1H), 5.75 (dd, J = 17.5, 10.5, 1H), 4.89 (dd, J = 17.5, 1.0, 1H), 4.85 (dd, J = 
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10.5, 1.0, 1H), 4.75 (m , 2H), 4.28 (s, 1H), 3.42 (m, 1H), 2.78 (dd, J = 18.0, 
4.5, 1H), 2.71 (m, 2H), 2.61 (dd, J = 18.0, 14.0, 1H), 2.46 (d, J = 18.0, 1H), 
2.19 (s, 3H), 1.91 (d, J = 18.0, 1H), 1.52 (m, 2H), 1.02 (s, 3H), and 0.98 (s, 
3H). 
MTPA Esterification of JBIR-65 Acetate (15). Acetate (15) was prepared 
in two 40 mL vials (two 1.7 mg samples), which were dried completely 
under high vacuum for 12 h. First, freshly distilled anhydrous pyridine (1 
mL) was prepared prior to the addition of a catalytic amount of 
dimethylaminopyridine to the solution. R-(-) and S-(+)-MTPA chloride (10 
mL) were added separately and the mixture stirred while gradually 
increasing the temperature from 45 °C to 65 °C. After 2.5 h, the reaction 
was quenched with 0.5 mL of MeOH. The products were then purified using 
reversed-phase HPLC (Kromasil 100-5-C18 250 × 10 mm, flow rate 2 
mL/min, UV 254 nm detection) under gradient conditions ranging from 
60% to 100% aqueous acetonitrile. The S-MTPA (16) and R-MTPA (17) 
esters eluted at 27.0 and 27.5 min, respectively. The molecular formulae 
(C31H33F3O7) of the MTPA esters were confirmed by ESI MS ([M+H]
+ m/z
at 575) and 1H NMR spectroscopy. The 1H chemical shifts around the 
stereogenic centers of the derivatives were assigned by 1H NMR spectra of 
16 and 17.
S-MTPA ester (16) of acetate (15): 1H NMR (600 MHz, DMSO-d6) δ
7.25-7.15 (m, 5H), 6.10 (br s, 1H), 5.75 (dd, J = 17.5, 10.5, 1H), 5.18 (s, 
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1H), 4.74 (dd, J = 17.5, 1.0, 1H), 4.70 (dd, J = 10.5, 1.0, 1H), 4.60 (m , 2H), 
3.49 (s, 3H), 3.46 (m, 1H), 2.74 (dd, J = 18.0, 4.5, 1H), 2.71 (m, 2H), 2.63 
(dd, J = 18.0, 14.0, 1H), 2.46 (d, J = 18.0, 1H), 2.19 (s, 3H), 1.91 (d, J = 
18.0, 1H), 1.52 (m, 2H), 1.01 (s, 3H), and 0.95 (s, 3H). 
R-MTPA ester (17) of acetate (15): 1H NMR (600 MHz, DMSO-d6) δ
7.26-7.10 (m, 5H), 6.08 (br s, 1H), 5.72 (dd, J = 17.5, 10.5, 1H), 5.21 (s, 
1H), 4.76 (dd, J = 17.5, 1.0, 1H), 4.72 (dd, J = 10.5, 1.0, 1H), 4.62 (m , 2H), 
3.49 (s, 3H), 3.45 (m, 1H), 2.75 (dd, J = 18.0, 4.5, 1H), 2.72 (m, 2H), 2.64 
(dd, J = 18.0, 14.0, 1H), 2.47 (d, J = 18.0, 1H), 2.18 (s, 3H), 1.89 (d, J = 
18.0, 1H), 1.50 (m, 2H), 1.02 (s, 3H), and 0.97 (s, 3H). 
Computational Analysis. The ground-state geometries were optimized by 
DFT calculations using Turbomole 6.5 with the basis set def-SV(P) for all 
atoms at the functional B3LYP/DFT level. The ground states were further 
confirmed by harmonic frequency calculations. The calculated ECD data 
corresponding to the optimized structures were obtained with TD-DFT at 
the functional B3LYP/DFT level at the basis set def2-TZVPP for all atoms. 
The CD spectra were simulated by overlapping each transition, where σ is 
the width of the band at 1/e height. ΔEi and Ri are the excitation energies and 
rotatory strengths for transition i, respectively. In the current work, the value 
of σ was 0.10 eV.
Antibacterial Assays. The in vitro antimicrobial activities of the 
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compounds were assessed against three representative Gram-positive 
bacteria, viz. Staphylococcus aureus (ATCC 6538p), Bacillus subtilis
(ATCC 6633), and Kocuria rhizophila (NBRC 12708), and three Gram-
negative bacteria, viz. Proteus hauseri (NBRC 3851), Salmonella enterica
(ATCC 14028) and Escherichia coli (ATCC 25922). The resultant data are 
presented in Table 3 as MIC values. The bacteria were grown overnight in 
LB broth at 37 °C harvested by centrifugation and then washed twice with 
sterile distilled water. Stock solutions of the compounds were prepared in 
DMSO. Each stock solution was diluted with Standard method broth (Difco) 
to prepare serial two-fold dilutions in the range of 100 to 0.8 mg/mL. Ten 
microliters of broth containing approximately 105 colony-forming units 
(cfu)/mL of the test bacteria were added to each well of a 96 well microtiter 
plate. The culture plates were incubated for 24 h at 37 °C.
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Table 4. 1H and 13C NMR data for Actinomadurol (13) in CD3OD
a
a 1H and 13C NMR were recorded at 900 and 225 MHz, respectively.
Position dC, type dH, mult (J in Hz)
1 82.1, CH 4.28, s
2 201.4, C
3 121.3, CH 6.35, br s
4 169.5, C
5 40.3, CH 3.13, dd (13.5, 2.0)
6a
6b
29.3, CH2 1.99, ddd (13.5, 2.0, 
2.0)
1.87, ddd (13.5, 13.5, 
4.0)















41.2, CH2 1.91, d (18.0)
2.22, d (18.0)
15 149.8, CH 5.83, dd (17.5, 11.0)
16a 110.3, 
CH2
4.94, dd (17.5, 1.0)
16b 4.83, dd (11.0, 1.0)
17 24.3, CH3 1.02, s
18 12.6, CH3 0.86, s
19a
19b
63.2, CH2 4.31, m
4.26, m
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4. Deinococcucins A−D, 
aminoglycolipids from Deinococcus sp., 
a gut bacterium of the carpenter ant 
Camponotus japonicus.
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II.4.1. Results and discussion 
Deinococcucin A (18) was isolated as an amorphous, colorless oil and 
contained an [M+H]+ ion at m/z 533.3756 in its high-resolution electrospray 
ionization mass spectroscopy (HRESIMS) data. The exact mass was 
consistent with the molecular formula C27H52N2O8, which provided three 
unsaturation equivalents. The infrared (IR) absorption peaks at 3360 and
1640 cm-1 indicated the presence of hydroxy and amide functional groups, 
respectively. The 13C nuclear magnetic resonance (NMR) data revealed the 
presence of 27 carbon signals, which were classified from the HSQC 
spectrum as two sp3 methyl (δC 22.8 and 13.9), 17 sp
3 methylene (δC 69.6-
29.1), six sp3 methine (δC 97.1, 72.6, 70.8, 70.8, 70.4 and 53.4) carbons and 
two carbonyl carbons (δC 171.1 and 169.3). 
The 1JCH direct connectivities between protons and carbons were 
established by analyzing the HSQC spectrum and the tabulated 1H and 13C 
NMR spectral data for 18, which are listed in Table 5. The planar structure 
of deinococcucin A (18) was elucidated by analyzing its COSY and HMBC 
data (Figure 12), revealing a hexose structure. The 1H-1H homonuclear 
couplings demonstrated the formation of a spin system from H-1¢ (δH 4.62) 
to H2-6¢ (δH 3.55 and 3.47). H-1¢/C-5¢ and H-5¢/C-1¢ HMBC correlations 
established the closure of the hexose ring. The exchangeable protons of 2¢-
NH (δH 7.56), 3¢-OH (δH 4.78), 4¢-OH (δH 5.00), and 6¢-OH (δH 4.45) were 
assigned in this hexose spin system based on the 1H-1H COSY correlations. 
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In addition, the HMBC correlations from 2¢-NH and H3-8¢ (δH 1.85) to the 
amide carbon C-7¢ (δC 169.3) established an N-acetyl group at the C-2¢
position. Another spin system was identified from the H-1/H-2 and H-2/2-
OH COSY correlations. The 2JCH coupling from H-2 to the carbonyl carbon 
C-3 constructed a 2,3-dihydroxypropanoic acid moiety. The last partial 
structure was identified as an alkyl amine hydrophobic chain starting from 
the NH group. The amide proton 3-NH showed a COSY correlation to H2-4. 
The lipophilic chain composed of highly overlapped methylene protons and 
a terminal methyl group (dH 0.85; dC 13.9) was deduced based on the 
molecular formula, the overlapped COSY correlations among the methylene 
protons, and the clear COSY correlation from a methylene proton (H2-18) to 
the methyl group (H3-19).  
The three partial structures, a hexose ring, 2,3-dihydroxypropanoic acid, 
and an alkyl amine hydrocarbon chain, were assembled based on the HMBC 
correlations. The hexose ring was connected to 2,3-dihydroxypropanoic acid 
through an ether based on the H-1¢/C-1 and H-1/C¢-1 HMBC correlations. 
The HMBC correlations from H-2 and 3-NH to the carbonyl carbon C-3 at 
δC 171.1 secured the connectivity from 2,3-dihydroxypropanoic acid to the 
hydrocarbon chain unusually starting at an NH group and not at a carbonyl 
carbon. Therefore, the planar structure of deinococcucin A (1) was 
elucidated as a new aminoglycolipid (Figure 12). 
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Figure 12. Key 1H-1H COSY and HMBC correlations of 18.
Deinococcucin B (19) was purified as a colorless oil with a molecular 
formula of C28H54N2O8 determined from its HRESIMS data. The 1D and 2D 
NMR spectroscopic data of 19 (Table 5) displayed almost identical features 
to those of 18. Careful analysis of the NMR data disclosed the presence of 
one additional sp3 methylene carbon in the lipid chain of 19 compared to 18, 
thus determining the structure of 19 as an analogue of 18 with a C16 alkyl 
chain. 
Deinococcucin C (20) was obtained as a colorless oil, and its molecular 
formula was deduced to be C27H50N2O8 based on its HRESIMS data. 
Careful comparison of the NMR spectroscopic data (Table 6) revealed that 
the 1H and 13C NMR spectra of 3 in DMSO-d6 were very similar to those of 
18 but that deinococcucin C (20) bears two overlapped sp2 methine carbons 
(dC 129.0), indicating that 3 possesses a double bond in the hydrocarbon 
chain. Further analysis of its 2D NMR spectra, including COSY, HSQC, and 
HMBC data, indicated that the structure of deinococcucin C (20) was 
analogous to that of 18 with an olefinic double bond in its chain. However, 
the overlapped 1H and 13C NMR resonances of the hydrocarbon chain 
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hampered the determination of the exact position and the geometry of the 
double bond, which required further analysis. 
For the exact assignment of the double bond position, a recently 
developed method utilizing olefin cross-metathesis and subsequent LC/MS 
analysis was applied.71 Cross-metathesis of 20 with methyl acrylate using 
the 2nd-generation Hoveyda-Grubbs catalyst yielded a UV-detectable 
product (Figure 13). The double bond positions could be simply deduced by 
comparing the mass changes between deinococcucin C ([M+H]+ at m/z 531) 
and the cross-metathesis product in the LC/MS data (Figure 13). The 
molecular mass of the deinococcucin C-derived cross-metathesis product 
was 504 ([M+H]+ at m/z 505), indicating a 26-Dalton decrease from the 
mass of deinococcucin C. This result can be easily explained by the removal 
of a C6H13 group (85 Daltons) and the addition of a CO2CH3 group (59 
Daltons) in the metathesis partner, methyl acrylate, during cross-metathesis, 
thus placing the double bond position at the seventh carbon from the chain 
terminus. Therefore, the double bond position was unequivocally 
established between C-12 and C-13.
Figure 13. Olefin cross-metathesis of deinococcucin C (20).
Regarding the geometry of the double bond, the 1H-1H coupling constant 
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between H-12 and H-13 could not be measured because these two protons 
overlap at dH 5.33. Instead, the 
13C chemical shifts were used to establish the 
configuration of the olefinic bond. Reportedly, the aliphatic carbons 
flanking a Z-olefin in a long hydrocarbon chain resonate at dC 28~30, while 
those next to an E-double bond appear at dC 42~43, clearly distinguishing 
the E/Z geometries.72,73 The chemical shifts of C-11 and C-14 were detected 
at dC 28.5, thus assigning the 12Z configuration.
Deinococcucin D (21) was isolated as a colorless oil. The molecular 
formula was assigned as C28H52N2O8 based on its HRESIMS data. Similar 
to the relationship between deinococcucins A (18) and C (20), 
deinococcucin D (21) has two more sp2 methine (dC 129.6) and two less sp
3
methylene carbons compared to 19. Detailed analysis of the 2D NMR 
spectra (Table 6) indicated that deinococcucin D also possesses an olefinic 
double bond in the lipid chain similar to 20. The location and geometry of 
the double bond in 21 were determined as 12Z by cross-metathesis and 13C 
chemical shift analysis, as shown for 20.
The relative configuration of the hexose ring was established by 
analyzing the 1H-13C and 1H-1H coupling constants and the ROESY NMR 
through-space correlations. The magnitude of 1JCH (170 Hz) between C-1¢
and H-1¢ was clearly indicative of an α-configuration,7 placing the anomeric 
proton (H-1¢) in an equatorial position. The large 1H-1H vicinal coupling 
constant (8.5 Hz) between H-2¢ and H-3¢ established their anti-relationship 
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and, therefore, axial positions. In addition, H-4¢ was assigned an axial 
position based on 3JHH (10.0 Hz) between H¢-3 and H¢-4. Lastly, the 
1H-1H 
coupling constant (9.0 Hz) of the H-5¢ doublet determined its axial position, 
and the H-2¢/H-4¢ ROESY correlation confirmed their relative 
configurations. Therefore, the hexose moiety was determined to be N-acetyl 
glucosamine (Figure 14). 
Figure 14. Strong ROESY correlations observed in the hexose moiety of 18.
To determine the absolute configuration of the glucosamine moiety in 
deinococcucin A (18), the compound was subjected to acid hydrolysis 
yielding glucosamine which was derivatized using hexamethyldisilazane 
(HMDS) and TMS-Cl and analyzed by gas chromatography-mass 
spectroscopy (GC/MS). The derivative of glucosamine from N-acetyl 
glucosamine in 18 exhibited a retention time that was consistent with that of 
the authentic D-glucosamine derivative.75
To determine the absolute configuration of deinococcucin A (18), the 
phenylglycine methyl ester (PGME) method was applied.76 Prior to this 
procedure, acid hydrolysis of 18 mainly yielded a 2,3-dihydroxypropanoic 
acid (22). The carboxylic acid group at C-1 in 22 was then derivatized with 
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S- or R-PGME to yield the S- or R-PGME amide (22a and 22b), respectively. 
The 1H chemical shifts of the relevant protons were assigned by analyzing 
the 1H NMR spectra of 22a and 22b. Calculating the ΔδS-R values 
established the absolute configuration as 2R (Figure 15).  
Figure 15. Degradation of 18 to 2,3-dihydroxypropanoic acid (22) and 
derivatization of 22 to S-and R-PGME amides. ΔδS-R values of 22a and 22b 
are noted in ppm in DMSO-d6.
The biological activities of deinococcucins A-D (18–21) were evaluated 
in several ways. Deinococcucins A-D (18–21) were neither cytotoxicity 
against human cancer cell lines (IC50 > 10 mM) or active against Gram 
positive and negative bacteria or fungi (MIC > 128 mM) (See the supporting 
information.).
Cancer chemoprevention is considered to play an important role in 
decreasing the risk of cancer development, involving the prevention, delay 
or reversal of carcinogenesis. One important cancer prevention strategy is to 
enhance the deactivation of radicals and electrophiles via phase II 
enzymes.77 Quinone reductase (QR), a representative phase II detoxification 
enzyme, is known to function as a cancer chemopreventative.78 The QR 
activity in Hepa 1c1c7 cells was enhanced in a dose-dependent manner over 
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a concentration range of 2.5–20 μM deinococcucins A (18) and C (20) 
without causing cytotoxicity. Deinococcucin C (20) induced QR activity by 
1.8, 2.2, 2.5, and 2.7 fold, and deinococcucin A (18) induced significant QR 
activity by 1.2, 1.3, 1.6, and 1.9 fold at concentrations of 2.5, 5, 10, and 20 
μM, respectively, as shown in Figure 16. However, no significant effects of 
deinococcucins B (19) and D (21) were observed (Figure 16). 
Figure 16. Effect of deinococcucins A-D (18-21) on the induction of QR 
in murine Hepa 1c1c7 cells. Cells were grown for 24 h and then exposed to 
the test compounds for 24 h. QR activities were measured in the cell lysates 
by reduction of a tetrazolium dye and expressed as nmol/min/mg protein. 
Values are the mean ±SD of four determinations. P < 0.05 (*), P < 0.01 (**) 
and P < 0.001 (***) indicate statistically significant differences from the 
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control group.
Reports on the chemistry of the genus Deinococcus are sparse. From the 
representative species D. radiodurans, a radiation-resistant species 
deinoxanthin was reported as a red pigment possibly responsible for the 
antioxidant activity of this species against hydroxy radicals produced by 
photochemical reactions.79 The other class of compounds from D. 
radiodurans consists of phosphoglycolipids.80,81 The deinococcucins are 
structurally most similar to the glucosamine-containing phosphoglycolipids, 
of which the gross structures were proposed in mixtures without rigorous 
spectroscopic analysis or biological evaluation.82 Our report of the new
aminoglycolipids deinococcucins A-D is the first full characterization of 
glycolipids, including the determination of the exact double bond position 
and the absolute configuration, from the genus Deinococcus. The similar 
structural features of the phosphoglycolipids from D. radiodurans and of the 
deinococcucins from the Deinococcus sp. that is most closely related to D. 
xinjiangensis, which is a phylogenetically distant species from D. 
radiodurans (Figure S28), indicate that the backbone of the deinococcucins 
could be a basic structural backbone of glycolipids in this genus.
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II.4.2. Experimental section
General Experimental Procedures. Optical rotations were measured 
using a Jasco P-1020 polarimeter. IR spectra were recorded using a Thermo 
Nicolet iS10 spectrometer. 1H, 13C, and 2D NMR spectra were obtained on a 
Bruker Avance 600 MHz spectrometer at the National Center for Inter-
University Research Facilities at Seoul National University (NCIRF). Low-
resolution electrospray ionization source mass spectra were acquired with an 
Agilent Technologies 6130 quadrupole mass spectrometer coupled with an 
Agilent Technologies 1200 series high-performance liquid chromatography 
(HPLC) instrument. High-resolution electrospray ionization (HRESI) mass 
spectra were acquired using a Thermo Scientific Q high-resolution mass 
spectrometer at the National Instrumentation Center for Environmental 
Management at Seoul National University. Semi-preparative HPLC 
separations were achieved with a Gilson 305 pump and a Shodex 101 RI 
detector. 
Collection of Carpenter Ants. Ant specimens were collected around a 
pond called Bandoji at the Seoul Zoo in Seoul Grand Park, Gwacheon-si, 
Gyeonggi-do on the mating flight season (April 2015). Ant nests under 
rocks were excavated by a spade and a short half-moon hoe. Collected 
specimens were identified as Japanese carpenter ant Camponotus japonicus 
(Hymenoptera: Formicidae) in the field based on external morphological 
characteristics. These collected ants were divided into several containers 
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using brushes and tweezers and transferred to the laboratory at Seoul 
National University on the same day.
Isolation and Classification of Strain SJN 1. Sixty queen ant specimens 
were washed with sterilized water and then soaked in 97% ethanol to 
remove the microbes on their exoskeleton. The queen ants were cut into 
three parts (head, thorax, and abdomen) using a razor blade. The cuticle of 
the abdomen was removed, and the intestinal parts were placed in a conical 
tube containing 20 mL of sterilized distilled water at 25 °C. The tube was 
vortexed, and 300-μL aliquots of the suspension were spread onto the 
surfaces of actinomycete isolation medium (1 L of distilled water, 22 g of 
actinomycete isolation medium, 18 g of agar, and 100 mg/L cycloheximide), 
A4 medium (1 L of distilled water, 18 g of agar, and 100 mg/L 
cycloheximide), A6 medium (1 L of distilled water, 18 g of agar, and 5 mg/L 
polymyxin B sulfate), A7 medium (1 L of distilled water, 18 g of agar, and 5 
mg/L kanamycin) and chitin-based agar medium (1 L of distilled water, 4 g 
of chitin, 18 g of agar, and 100 mg/L cycloheximide) plates using 
autoclaved foam plugs (2 cm in diameter) and spreaders. The plates were 
incubated at 25 °C for 3 weeks. Strain SJN1 was isolated from a chitin-
based agar plate. Colonies were repeatedly inoculated onto fresh YEME 
agar (1 L of distilled water, 18 g of agar, 4 g of yeast extract, 4 g of glucose, 
and 10 g of malt extract) plates to obtain a pure culture. Strain SJN1 was 
identified as a Deinococcus sp. most closely related to D. xinjiangensis
based on its 16S rDNA sequence. (GenBank accession number: MF102142). 
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Analysis of 16S rDNA sequences constructed a neighbor-joining 
phylogenetic tree to show the relationship between isolate SJN1 and the 
type strains of closely related species of the genus Deinococcus (Figure 
S28). 
Cultivation and Isolation. The strain was cultivated in 50 mL of modified 
K medium (2 g of yeast, 2 g of glucose, 3 g of mannitol, 5 g of soytone, 5 g 
of starch and 1 g of calcium carbonate in 1 L of distilled H2O). After 
culturing the strain for 3 days on a rotary shaker at 180 rpm and 30 °C, 10 
mL of the culture was inoculated into 1 L of modified K medium in a 2.8-L 
Fernbach flask and incubated at 180 rpm and 30 °C for 7 days. The entire 
culture (80 L) was extracted twice with ethyl acetate (EtOAc) and then 
concentrated in vacuo to yield 5 g of dry material. After extraction, the 
extract was fractionated by C18 reversed-phase vacuum flash 
chromatography using a sequential mixture of MeOH and H2O as the eluent 
(five fractions eluted with an MeOH/H2O gradient from 20% to 100%). 
After fractionation, deinococcucins A-D (18-21) were found in the 80% and 
100% MeOH/H2O fractions. Each fraction was then subjected to reversed-
phase HPLC (250 × 10 mm Kromasil 100-5-C18 column, flow rate of 2 
mL/min, RI detection, isocratic elution with 70% aqueous acetonitrile). 
Each compound was further purified (250 × 10 mm Kromasil 100-5-C18
column, flow rate of 2 mL/min, RI detection, isocratic elution with 82% 
aqueous MeOH) to yield deinococcucins A-D (18-21) (20, 15, 10, and 10 
mg with the yields of 0.25, 0.18, 0.13, 0.13 mg/L) at retention times of 29, 
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55, 31 and 76 min, respectively.
Deinococcucin A (18): Colorless oil; [α]25D -25.0 (c 0.5, MeOH); IR (neat) 
νmax 3360, 1640 cm
-1; 1H and 13C NMR data in Table 5; ESI MS m/z
533.3756 [M+H]+ (calcd for C27H53N2O8, m/z 533.3753).
Deinococcucin B (19): Colorless oil; [α]25D -25.0 (c 0.5, MeOH); IR (neat) 
νmax 3280, 1690 cm
-1; 1H and 13C NMR data in Table 5; ESI MS m/z
547.3946 [M+H]+ (calcd for C28H55N2O8, m/z 547.3943).
Deinococcucin C (20): Colorless oil; [α]25D -17.0 (c 0.5, MeOH); IR (neat) 
νmax 3300, 1630 cm
-1; 1H and 13C NMR data in Table 6; ESI MS m/z
531.3650 [M+H]+ (calcd for C27H51N2O8, m/z 531.3649).
Deinococcucin D (21): Colorless oil; [α]25D -35.0 (c 0.5, MeOH); IR (neat) 
νmax 3350, 1640 cm
-1; 1H and 13C NMR data in Table 6; ESI MS m/z
545.3750 [M+H]+ (calcd for C28H53N2O8, m/z 545.3748).
Determination of the Double Bond Position in Deinococcucins C (20) 
and D (21). 0.5 mg of deinococcucins C (20) or D (21) was dissolved in a 
10:1 mixture of CH2Cl2 and methyl acrylate (0.5 mL) to which 50 mg (5 
mol%) of 2nd-generation Hoveyda-Grubbs catalyst was subsequently added. 
The reaction mixture was stirred at room temperature for 2 h and injected 
into the LC/MS system without any treatment (100 × 4.6 mm Phenomenex 
C18 (2) column, gradient elution from 10 to 100% aqueous acetonitrile with 
0.1% formic acid over 20 min and 100% acetonitrile with 0.1% formic acid 
after 20 min). The metathesis products of 20 and 21 commonly yielded an 
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[M+H]+ ion at m/z 505 at a retention time of 9.2 min in the LC/MS analysis. 
The double bond positions of 20 and 21 were determined using the 
previously reported method based on the mass spectrometric data.72
Analysis of the Absolute Configuration of N-Acetyl Glucosamine in 
Deinococcucin A (18). Deinococcucin A (3 mg) was dissolved in 3 N HCl 
(0.5 mL) and stirred at 80 °C for 2 h. After the solution had cooled to rt, the 
HCl was evaporated in vacuo to yield the hydrolysate that contained 
glucosamine originating from N-acetyl glucosamine. HMDS and TMS-Cl 
(50 μL, v/v = 2:1) were added to the hydrolysate in pyridine (0.5 mL). After 
being stirred at 60 °C for 30 min, the mixture was dried in vacuo and 
separated using H2O and CH2Cl2 (1 mL, v/v = 1:1). The CH2Cl2 layer was 
injected into a gas chromatograph equipped with an HP5 column (0.32 mm 
× 30 m). The injector and detector temperatures were maintained at 200 °C. 
During the analysis, the temperature of the GC column was controlled as 
follows: 60 °C for 3 min, 60–200 °C at 4 °C/min, and 200 °C for 3 min. The 
glucosamine derivative from the hydrolysate of 18 was detected at a 
retention time of 32.77 min. Authentic D-glucosamine and L-glucosamine 
samples were treated and analyzed using the same procedures. The 
derivatives of D-glucosamine and L-glucosamine were detected at 32.77 min 
and 32.85 min, respectively. Co-injection of the silylated derivative of the 
hydrolysate and authentic D-glucosamine gave a single peak at 32.76 min, 
thereby determining the absolute configuration of the glucosamine in 18 as 
the D-form.
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Acid Hydrolysis of Deinococcucin A (18). Deinococcucin A (18) (5.5 mg) 
was hydrolyzed in 6 N HCl (0.5 mL) at 40 °C. After 2 h, the reaction vial 
was cooled in ice water for 3 min. Then, the HCl was removed in vacuo, and 
the dry material was resuspended in 0.5 mL of H2O and dried three times to 
completely remove the residual HCl. The reaction mixture was extracted 
with CHCl3. The CHCl3 layer was chromatographed over normal-phase 
silica gel (Waters Sep-Pak Vac 6 cc) using a solvent composed of a 30:1 
mixture of CHCl3-MeOH to yield the 2,3-dihydroxypropanoic acid (22, 2.0 
mg).
2,3-Dihydroxypropanoic Acid (22): 1H NMR (600 MHz, DMSO-d6) δ 9.5 
(s, OH), 6.1 (s, OH), 4.9 (s, OH), 4.47 (t, J = 5.0, 1H), 4.04 (dd, J = 12.5, 
5.5, 1H) and 3.72 (dd, J = 12.5, 5.5, 1H).          
PGME Amide Derivatization of 2,3-Dihydroxypropanoic Acid (22). 
First, 2 mg of 2,3-dihydroxypropanoic acid (22) from deinococcucin A (18) 
was dried under high vacuum for 24 h and dissolved in 500 mL of 
dimethylformamide (DMF). To the DMF solution of 2,3-
dihydroxypropanoic acid (22) and S- or R-PGME were added 
benzotriazolyloxy-tris[pyrrolidino]-phosphonium hexafluorophosphate 
(PyBOP) (4.4 mg, 8.4 mmol) and N-methylmorpholine (100 mL) at room 
temperature. After stirring for 1 h, 5% HCl solution and (1 mL) and EtOAc 
(2 mL) were added to the reaction mixture. The EtOAc layer was washed 
with saturated NaHCO3 solution and brine. The S- or R-PGME amide 
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products ([M+H]+ m/z 254) were observed in LC/MS analysis (100 × 4.6 
mm, 5 mm, Phenomenex C18 (2) column; gradient elution from 10 to 100% 
aqueous acetonitrile with 0.1% formic acid over 20 min). After the reaction 
mixture was dried, the S- and R-PGME amide products (22a and 22b) were 
purified by reserved-phase HPLC (250 × 10 mm, 5 mm, Kromasil C18
column; flow rate of 2 mL/min; UV detection at 254 nm; 50-100% aqueous 
acetonitrile gradient), eluting at retention times of 28 and 30 min, 
respectively. 
(S)-PGME Amide of 2,3-Dihydroxypropanoic Acid (22a): 1H NMR (600 
MHz, DMSO-d6) δ 8.58 (s, NH), 7.29-7.24 (m, 5H), 5.63 (s, 1H), 5.11 (s, 
OH), 4.54 (t, J = 6.5, 1H), 3.95 (dd, J = 12.0, 7.5, 1H), 3.88 (s, OH), 3.73 (s, 
3H), and 3.58 (dd, J = 12.0, 7.5, 1H).
(R)-PGME Amide of 2,3-Dihydroxypropanoic Acid (22b): 1H NMR 
(600 MHz, DMSO-d6) δ 8.60 (s, NH), 7.31-7.26 (m, 5H), 5.61 (s, 1H), 5.22 
(s, OH), 4.53 (t, J = 6.5, 1H), 3.90 (dd, J = 12.0, 7.5, 1H), 3.87 (s, OH), 3.71 
(s, 3H), and 3.52 (dd, J = 12.0, 7.5, 1H).
QR Assays. The QR activities were determined spectrophotometrically 
using a previously reported modified microtiter method with murine Hepa-
1c1c7 cells.38 In this assay, 0.1% dimethyl sulfoxide (DMSO) was used as a 
negative control, and β-naphthoflavone (2 μM) was used as a positive 
control. 
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Table 5. 1H and 13C NMR Data for Deinococcucins A (18) and B (19) in 
DMSO-d6
a
a 1H and 13C data were recorded at 600 and 125 MHz, respectively.
Deinococcucin A (18) Deinococcucin B (19)
Position dC, type dH, mult
(J in Hz)
dC, type dH, mult
(J in Hz)
1 69.6, CH2 3.63, m
3.45, m






















































1´ 97.1, CH 4.62, d (3.5) 97.0, CH 4.61, d (3.5)
2´ 53.4, CH 3.67, dd 
(8.5, 3.5)
53.4, CH 3.67, dd 
(8.5, 3.5)
3´ 70.8, CH 3.44, dd 
(10.0, 8.5)
70.7, CH 3.41, dd 
(10.0, 8.5)
4´ 70.4, CH 3.12, ddd
(10.0, 9.0, 2.5)
70.4, CH 3.16, ddd 
(10.0, 9.0, 2.5)
5´ 72.6, CH 3.35, ddd 
(9.0, 5.0, 2.5)
































Table 6. 1H and 13C NMR Data for Deinococcucins C (20) and D (21) in 
DMSO-d6
a
a 1H and 13C data were recorded at 600 and 125 MHz, respectively.
Deinococcucin C (20) Deinococcucin D (21)
Position dC, type dH, mult
(J in Hz)
dC, type dH, mult
(J in Hz)
1 69.6, CH2 3.63, m
3.49, m
69.6, CH2 3.62, m
3.47, m
2 70.8, CH 4.00, dd
(5.5, 3.0)
70.6, CH 4.00, dd
(5.5, 3.0)


























































1´ 97.1, CH 4.62, d (3.5) 97.0, CH 4.61, d (3.5)
2´ 53.4, CH 3.67, dd 
(8.5, 3.5)
53.4, CH 3.67, dd 
(8.5, 3.5)
3´ 70.8, CH 3.44, dd 
(10.0, 8.5)
70.7, CH 3.41, dd 
(10.0, 8.5)
4´ 70.4, CH 3.16, ddd 
(10.0, 9.0, 2.5)
70.4, CH 3.16, ddd 
(10.0, 9.0, 2.5)
5´ 72.6, CH 3.39, ddd 
(9.0, 5.0, 2.5)


































In our search for new bioactive compounds from marine actinobacteria,5 I
selectively isolated actinomycete strains from marine sediment samples 
from Suncheon Bay, Republic of Korea. Suncheon Bay is a tideland with 
high biodiversity that provides habitats for migratory birds, various plants 
and animals as well as microorganisms.6 Actinomycete strains from 
Suncheon Bay sediments were subjected to chemical profiling by LC/MS 
analysis. Through the profiling process, one of the strains, Streptomyces sp. 
SSC21, was identified to produce a series of compounds, each containing a 
sulfur atom, based on mass spectroscopic data ([M+Na]+:[M+2+Na]+ ≈
100:5).7 This information, along with corresponding UV and mass spectra, 
suggested that these compounds were unlikely to have been previously 
reported, thus prompting further chemical analysis. In this paper, I discuss 
the isolation and identification of the structures of the sulfur-bearing 
compounds, named suncheonosides A-D (1-4), and their biological activity 
with respect to insulin sensitivity.
The secondary metabolite profiles of the 80 actinobacterial strains isolated 
from the gut of a P. brevitarsis grub were chemically analyzed by LC/MS. 
This chemical analysis led to the discovery of two new flavonoid-like 
compounds, which are dominantly found in plants but really uncommon as 
bacterial metabolites. The epimeric compounds JS8A and B (6-7) were 
purified by HPLC using a chiral column (a polysaccharide-based 
immobilizing cellulose to silica gel). Their structures were determined 
mainly by spectroscopic analysis of NMR and mass data. The absolute 
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configurations were established by time-controlled acetylation followed by 
the application of the modified Mosher’s method using MTPA. Moreover, 
the comparative full genome analysis of the strain JS8 and the producer 
(CNB-689) of actionflavoside, will be discussed along with their structures.
In our search for new bioactive compounds, I focused on the secondary 
metabolites of rare actinobacteria, as illustrated by the discovery of a 
structurally new benzofuran glycoside and indole alkaloids from an 
Amycolatopsis strain isolated from a marine sponge.8 A continuation of 
these studies led us to Actinomadura strain KC 191 which was seen to 
inhibit neighboring bacterial colonies on isolation plates seeded with a 
suspension of an agricultural soil sample. Extracts of strain KC 191 showed 
significant antibacterial activity against Bacillus subtilis, Staphylococcus 
aureus, Kocuria rhizophila, Proteus hauseri and Salmonella enterica strains 
(MIC = 0.39 ~ 3.12 mg/mL), prompting the scale-up of the culture. 
Comprehensive chemical analysis of the resultant extracts led to the 
identification of a new antibacterial norditerpenoid, actinomadurol (13), and 
its congener, JBIR-65 (14), which was previously reported albeit without 
stereochemical analysis.25 Here, I report on the structural determination, 
including the absolute configurations of actinomadurol (13) and JBIR-65 
(14) and their antibiotic activities.
This study focused on the ecosystem of the carpenter ant, Camponotus 
japonicus, which is a dominant ant species in East Asia.70 I collected 
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carpenter ants in Seoul Grand Park, Republic of Korea, and isolated 
bacterial strains from the ant specimens. Chemical analysis of the bacterial 
metabolites by liquid chromatography-mass spectroscopy (LC/MS) revealed 
that strain SJN1, which was most closely related to Deinococcus 
xinjiangensis and isolated from the gut of queen specimens, produced a 
series of previously unreported compounds that were invisible under UV 
detection but distinctly detected in mass spectra ([M+H]+ ions at m/z 
531~547). Further scaling up the culture of SJN1 and chromatographic 
isolation of these compounds by HPLC with refractive index (RI) detection 
resulted in the discovery of four new aminoglycolipids, deinococcucins A-D 
(18-21). Here, I report the structural determination, including the absolute 
configurations, and the biological activities of deinococcucins A-D (18-21), 
rare metabolites from the genus Deinococcus.
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Figure S1. 1H NMR spectrum (600 MHz) of suncheonoside A (1).
Figure S2. 13C NMR spectrum (150 MHz) of suncheonoside A (1).
Figure S3. 1H NMR spectrum (600 MHz) of suncheonoside B (2).
Figure S4. 13C NMR spectrum (150 MHz) of suncheonoside B (2).
Figure S5. 1H NMR spectrum (600 MHz) of suncheonoside C (3).
Figure S6. 13C NMR spectrum (150 MHz) of suncheonoside C (3).
Figure S7. 1H NMR spectrum (600 MHz) of suncheonoside D (4).
Figure S8. 13C NMR spectrum (150 MHz) of suncheonoside D (4).
Figure S9. 1H NMR spectrum (600 MHz) of enzymatic hydrolysis (5).
Figure S10. 1H NMR spectrum (850 MHz) of JS8 A (6).
Figure S11. 13C NMR spectrum (212.5 MHz) of JS8 A (6).
Figure S12. 1H NMR spectrum (850 MHz) of JS8 B (7).
Figure S13. 13C NMR spectrum (212.5 MHz) of JS8 B (7).
Figure S14. 13C NMR spectrum (850 MHz) of JS8 A (6) labeled with [2-
13C]sodium acetate.
Figure S15. 13C NMR spectrum (850 MHz) of JS8 A (6) labeled with [1-
13C]sodium acetate.
Figure S16. 1H NMR spectrum (900 MHz) of Actinomadurol (13).
Figure S17. 13C NMR spectrum (225 MHz) of Actinomadurol (13).
Figure S18. DEPT NMR spectrum (225 MHz) of actinomadurol (13).
Figure S19. 1H NMR spectrum (900 MHz) of JBIR-65 (14).
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Figure S21. 1H NMR spectrum (600 MHz) of acetate (15) of JBIR-65 (14).
Figure S22. 1H NMR spectrum (600 MHz) of S-MTPA ester (16) for JBIR-65 
(14).
Figure S23. 1H NMR spectrum (600 MHz) of R-MTPA ester (17) for JBIR-65 
(14).
Figure S24. 1H NMR spectrum (600 MHz) of deinococcucin A (18).
Figure S25. 13C NMR spectrum (150 MHz) of deinococcucin A (18).
Figure S26. 1H NMR spectrum (600 MHz) of deinococcucin B (19).
Figure S27. 13C NMR spectrum (150 MHz) of deinococcucin B (19).
Figure S28. 1H NMR spectrum (600 MHz) of deinococcucin C (20).
Figure S29. 13C NMR spectrum (150 MHz) of deinococcucin C (20).
Figure S30. 1H NMR spectrum (600 MHz) of deinococcucin D (21).
Figure S31. 13C NMR spectrum (150 MHz) of deinococcucin D (21).
Figure S32. 1H NMR spectrum (600 MHz) of 2,3-dihydroxy-propanoic acid
(22).
Figure S33. 1H NMR spectrum (600 MHz) of (S)-PGME amide (22a) of 
2,3-dihydroxy-propanoic acid (22).
Figure S34. 1H NMR spectrum (600 MHz) of (R)-PGME amide (22b) of 
2,3-dihydroxy-propanoic acid (22).
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Figure S1. 1H NMR spectrum (600 MHz) of suncheonoside A (1) in pyridine-d5.
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Figure S2. 13C NMR spectrum (150 MHz) of suncheonoside A (1) in pyridine-d5.
99
Figure S3. 1H NMR spectrum (600 MHz) of suncheonoside B (2) in pyridine-d5
.
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Figure S4. 13C NMR spectrum (150 MHz) of suncheonoside B (2) in pyridine-d5.
101
Figure S5. 1H NMR spectrum (600 MHz) of suncheonoside C (3) in pyridine-d5.
102
Figure S6. 13C NMR spectrum (150 MHz) of suncheonoside C (3) in pyridine-d5.
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Figure S9. 1H NMR spectrum (600 MHz) of enzymatic hydrolysis (5) in pyridine-d5.
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Figure S10. 1H NMR spectrum (850 MHz) of JS8 A (6) in DMSO-d6.
107
Figure S11. 13C NMR spectrum (212.5 MHz) of JS8 A (6) in DMSO-d6.
.
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Figure S12. 1H NMR spectrum (850 MHz) of JS8 B (7) in DMSO-d6.
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Figure S13. 13C NMR spectrum (212.5 MHz) of JS8 B (7) in DMSO-d6.
110
Figure S14. 13C NMR spectrum (212.5 MHz) of JS8 A (6) labeled with [2-13C]sodium acetate.
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Figure S15. 13C NMR spectrum (212.5 MHz) of JS8 A (6) with labeled [1-13C]sodium acetate.
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Figure S16. 1H NMR spectrum (900 MHz) of actinomadurol (13) in CD3OD.
113
Figure S17. 13C NMR spectrum (225 MHz) of actinomadurol (13) in CD3OD.
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Figure S18. DEPT NMR spectrum (225 MHz) of actinomadurol (13) in CD3OD.
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Figure S19. 1H NMR spectrum (900 MHz) of JBIR-65 (14) in CD3OD.
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Figure S20. 13C NMR spectrum (225 MHz) of JBIR-65 (14) in CD3OD.
117
Figure S21. 1H NMR spectrum (600 MHz) of acetate (15) of JBIR-65 (14) in CD3OD.
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Figure S22. 1H NMR spectrum (600 MHz) of S-MTPA ester (16) for JBIR-65 (14) in DMSO-d6.
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Figure S23. 1H NMR spectrum (600 MHz) of R-MTPA ester (17) for JBIR-65 (14) in DMSO-d6.
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Figure S24. 1H NMR spectrum (600 MHz) of deinococcucin A (18) in 
DMSO-d6.
Figure S25. 13C NMR spectrum (150 MHz) of deinococcucin A (18) in 
DMSO-d6.
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Figure S26. 1H NMR spectrum (600 MHz) of deinococcucin B (19) in 
DMSO-d6.
Figure S27. 13C NMR spectrum (150 MHz) of deinococcucin B (19) in 
DMSO-d6.
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Figure S28. 1H NMR spectrum (600 MHz) of deinococcucin C (20) in 
DMSO-d6.
Figure S29. 13C NMR spectrum (150 MHz) of deinococcucin C (20) in 
DMSO-d6.
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Figure S30. 1H NMR spectrum (600 MHz) of deinococcucin D (21) in 
DMSO-d6.
Figure S31. 13C NMR spectrum (150 MHz) of deinococcucin D (21) in 
DMSO-d6.
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Figure S32. 1H NMR spectrum (600 MHz) of 2,3-dihydroxy-propanoic acid (22) in DMSO-d6.
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Figure S33. 1H NMR spectrum (600 MHz) of (S)-PGME amide (22a) of 2,3-dihydroxy-propanoic acid (22) in DMSO-d6.
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Experimental CD of 13
Calculated ECD of 13 (1S, 5R, 7R, 10S, 13R)
Calculated ECD of ent-13 (1R, 5S, 7S, 10R, 13S)
Figure S37. Experimental CD spectra of 13, calculated ECD spectra of 13 (1S, 5R, 
7R, 10S, 13R), and ent-13 (1R, 5S, 7S, 10R, 13S).







Experimental CD of 14
Calculated ECD of 14 (1S, 5R, 10S, 13R)




Figure S38. Experimental CD spectra of 14, calculated ECD spectra of 14 (1S, 5R, 
10S, 13R), and ent-14 (1S, 5R, 10S, 13S).
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Figure S39. A neighbour-joining tree based on 16S rRNA gene sequences showing 
the relationship between isolate KC191 and the type strains of closely related 
species of the genus Actinomadura. Asterisks represent the corresponding branches 
that were also found in the trees created by both the maximum-likelihood and 
maximum-parsimony methods. Actinomadura echinospora IFO 14042T was used 
as an outgroup. Bootstrap values (>50 %) based on 1000 replications are shown at 
the nodes. Bar, 0.005 substitution per site.
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Figure S40. Phylogenetic tree reconstructed from a comparative analysis of 
16S rRNA gene sequences showing the relationship between strain SJN1 
and type strains of Deinococcus genus. Bootstrap values (expressed as 
percentages of 1000 replications) greater than 50 % are shown at branch 
points. Bar, 0.01 substitutions per nucleotide position.
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Table S1. ECD calculation of actinomadurol (13)
total energy     = -1039.04112
kinetic energy    = 1029.42618
potential energy .= -2068.46730
Parameters of Level DFT
DFT settings (Functional B3-LYP / Gridsize M3)
Geometry optimization options (Energy 10-6 Hartree, Gradient norm │dE / 
dxyz│= 10-3 Hartree/Bohr)
Energy minimized coordinates of actinomadurol at the basis set def-SV(P) 
for all atoms (Å).
Atom X Y Z Atom X Y Z
C -3.1063 5.3704 0.7826 H 3.981 4.8719 1.1187
C -3.2452 3.9263 0.9258 H 4.767 6.0644 -0.0805
C -2.2488 3.1769 1.4458 C -0.2587 5.0545 -0.2128
H -4.1662 3.4727 0.5508 H 0.703 4.5393 -0.3688
C -0.9644 3.8055 1.9553 H -1.0399 4.5079 -0.7712
C -0.6036 5.1791 1.2936 H -0.1776 6.061 -0.6533
C -1.8881 6.0569 1.43 H -4.3578 1.6085 1.9071
H -2.1185 6.1335 2.519 H -2.6399 7.4784 0.4028
O -1.7815 7.3329 0.8631 H 2.3142 3.0157 2.6085
O -3.9108 6.0679 0.1804 H 1.232 2.3121 4.4315
C 0.6226 5.7707 2.0307
C 1.5006 4.9874 2.6996
C 1.3415 3.4911 2.8558
C 0.2629 2.8874 1.9551
H 0.6504 2.7471 0.9308
H 0.0259 1.8835 2.3465
H -1.1569 4.0244 3.0276
O 1.0483 3.2469 4.2387
C -2.4338 1.6814 1.6026
O -3.7183 1.2033 1.2963
H -2.1253 1.3909 2.6316
H -1.742 1.1546 0.9195
C 0.8917 7.2609 1.8944
C 1.9188 7.8083 2.8884
H 1.2317 7.4603 0.8585
H -0.0434 7.8287 1.9905
C 3.1854 6.9308 2.9861
H 1.4628 7.8673 3.8956
H 2.1888 8.8434 2.6048
C 2.7212 5.5315 3.4233
H 2.4914 5.5541 4.5057
H 3.5548 4.81 3.3285
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C 3.902 6.9429 1.6457
C 4.1495 7.5146 4.0414
H 3.6456 7.6128 5.0209
H 4.508 8.5173 3.7437
H 5.0341 6.8651 4.1725
C 4.2303 5.9087 0.8635
H 4.186 7.9522 1.3093
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Table S2. ECD calculation of JBIR-65 (14)
total energy      =  -1037.86773
kinetic energy    =  1069.267634
potential energy  .= -2148.808023
Parameters of Level DFT
DFT settings (Functional B3-LYP / Gridsize M3)
Geometry optimization options (Energy 10-6 Hartree, Gradient norm │dE / 
dxyz│= 10-3 Hartree/Bohr)
Energy minimized coordinates of JBIR-65 at the basis set def-SV(P) for all 
atoms (Å).
Atom X Y Z Atom X Y Z
C -6.1717 2.6558 -1.5063 H -3.8901 1.061 0.3717
C -7.4782 3.0777 -0.8246 H -4.3835 1.3031 2.8676
C -8.254 1.8659 -0.2952 H -4.187 -4.5719 0.5733
C -7.2826 3.7935 -0.0053 H -5.1494 -2.529 1.0607
C -8.1138 3.6184 -1.5491 C -1.5024 -0.5173 2.3483
C -7.4298 0.9775 0.689 H -0.4598 -0.8517 2.2244
C -9.1932 2.197 0.1877 H -1.5201 0.25 3.1383
H -8.5514 1.2403 -1.1581 H -2.1041 -1.3742 2.7014
C -5.2475 1.8529 -0.5616
H -5.632 3.5342 -1.8972
H -6.4095 2.0319 -2.3866
C -6.0503 0.657 0.0452
C -4.0887 1.2373 -1.405
C -3.2511 0.0655 -0.8212
C -4.137 -0.9455 -0.0451
H -5.1318 -0.2416 0.887
H -6.3191 0.0501 -0.8338
C -5.7118 -1.0131 1.4194
H -4.592 0.3265 1.6635
H -4.5939 2.8333 0.4514
C -5.3204 3.5763 0.8205
H -3.7848 3.3985 -0.0441
H -4.16 2.3366 1.333
C -7.3207 1.6269 2.088
H -6.7316 2.5548 2.0552
H -6.8373 0.9495 2.8132
H -8.3098 1.9035 2.5009
C -8.2092 -0.3601 0.7951
C -2.4073 -0.6231 -1.9322
H -1.0913 -1.0808 -1.2698
H -2.2015 0.1246 -2.7094
H -2.9682 -1.4485 -2.3927
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O -0.88 -0.1093 -0.1156
C -1.1725 -2.1097 -0.877
O -0.2406 -1.065 -1.9751
H -2.1562 0.5913 0.1285
H 0.2149 -0.3474 0.9215
O -0.0115 -1.6553 1.6998









인류에게 있어서 미생물 기원 생리활성 천연물질은 질병 치료를
위한 신약 개발, 특히 항생제, 항암제 등의 개발의 중심축으로 자리한다. 
2015 년, Streptomyces avermitilis 에서 유래한 천연물
아버맥틴(avermectin)의 발견과 이로부터 구충제
이버맥틴(ivermectin)의 개발에 대한 공로가 인정되어 물질 발견자인
일본 기타사토대학의 오무라 교수와 미국 드루대 캠벨 교수가 노벨
생리의학상을 수상하였다. 이러한 수상으로부터 천연물 유래 신약
개발의 중요성을 짐작해볼 수 있다. 뿐만 아니라 2012 년에 작성된
통계에 따르면 미생물 유래 생리활성물질은 약 70,000 종이 보고되었고
이들로부터 약 450~500 종류의 신약이 개발되었다. 이것은 약
0.64~0.71%의 비율로서 합성 화합물로부터 신약이 개발되는 비율인 약
0.025%, 전체 천연물로부터 신약이 개발되는 비율인 0.25%에 비하여
월등히 높다고 볼 수 있으며 이는 미생물 유래 천연물의 우수성을
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입증하는 것이라 여겨진다. 이러한 미생물로부터 유래한 신규 생리 활성
물질을 발견하고자 하는 노력의 일환으로 다양한 환경 (해양, 농토, 
곤충의 장내)에서 얻어진 다양한 종류의 박테리아 균주 (Streptomyces, 
Actinomadura, Deinococcus sp.)로부터 유력한 이차대사산물 생산
물질들을 분리, 구조 규명하였다.
1. 순천만에서 분리된 Streptomyces sp.가 생산하는 생리활성
이차대사물질 연구
Streptomyces 에 속하는 SSC21 균주는 전라남도 순천시
순천만에서 채집된 퇴적물에서 분리 되었다. 순천만은 강물을 따라
유입된 토사와 유기물 등이 바닷물의 조수 작용으로 퇴적되어 생긴
곳으로 오염원이 적어 다양한 생물이 풍부하게 발달되어있는
습지보존지역이다. 따라서 이러한 지형적, 환경적 특이성이 새로운
균주를 얻을 수 있는 적절한 장소라 생각되어 채집이 시행되었다. 
LC/MS 를 이용한 화학적 분석을 통해 SSC21 균주가 생산하는 신규
물질 4 개를 발견할 수 있었고, 이를 Suncheonosides A-D 라
명명하였다. 특히, 특이한 mass spectrum 의 분석을 통해 이 물질이
황을 포함하는 것임을 예측할 수 있었다. Suncheonoside 의 평면구조는
1H, 13C, COSY, HSQC, HMBC, ROESY 등의 NMR 자료 및 MS 등의
다양한 분광학적 분석을 통해 hexasubstituted benzothioate 
glycoside 임이 밝혀졌다. 당의 입체구조를 분석하기 위해서 ROESY 
분석, 1H-13C 결합상수 분석, 화학 반응이 적용되었으며 그 결과 L-
rhamnose 임을 밝힐 수 있었다 (Figure 1). Sunchenosides A, B 와










(a)       
(b)
Figure 1. (a) The structures of suncheonosides A, B, C and D. (b) 
The observed strong ROESY correlations in the hexose moiety and 
key ROESY correlations and distances between protons of 
suncheonoside A.
2. 흰점박이꽃무지 애벌레의 장에서 분리된 Streptomyces sp.가
생산하는 생리활성 이차대사물질 연구
Streptomyces 균주인 JS8 은 흰점박이꽃무지 애벌레의 장에서
분리되었다. 흰점박이꽃무지 애벌레는 초가지붕에서 채집되거나 일부
농가에서 사육해 판매하던 곤충으로, 주로 약용으로 이용된다. 조선
시대에 편찬된 의학서적인 <동의보감>에는 “간 질환 등 성인병 치료
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효과가 있다.”고 기술돼 있다. 따라서 약용곤충으로부터 새로운
생리활성 물질을 찾고자 실험을 진행하였다. 흰점박이꽃무지
애벌레로부터 약 80 개의 균주를 얻을 수 있었으며 그 중 균주 JS8 는
LC/MS 의 화학적 분석을 통해 신규 물질을 생산함을 예상할 수 있었다. 
1H, 13C, COSY, HSQC, HMBC, ROESY 등의 NMR 자료 및 MS 등의
다양한 분광학적 기법을 사용하여 새로운 플라보노이드 계열 물질 JS8 
A 와 B 를 생산함을 밝힐 수 있었다. 특히, JS8 A 와 B 는 에피머
관계를 이루고 있어 카이랄 HPLC 를 이용하여 분리될 수 있었다. 
입체구조 결정을 위해서는 time-controlled acetylation 과 MTPA 를
이용한 modified Mosher 방법이 적용되었다 (Figure 2). 두 물질의
생리활성 연구가 진행 중에 있다.
Figure 2. Using time-controlled acetylation and modified Mosher 
method to determine the absolute configuration of JS8 A.
3. 영국 농토에서 분리된 Actinomadura sp.가 생산하는 생리활성 이차대
사물질 연구
새로운 이차대사물질인 actinomadurol 은 희소방선균인
Actinomadura 균주 KC 191로부터 기지 물질인 JBIR-65와 함께 분리
되었다. 균주 KC 191은 영국 New castle 지역의 농토에서 얻어진 균주
로써 균주 동정 결과 희소방선균인 Actinomadura sp. 로 결정되었다. 
희소방선균에서 생산되는 물질 Actinomadurol의 평면 구조는 1H, 13C, 
COSY, HSQC, HMBC, NOESY 등의 NMR 자료를 바탕으로 하여 매우
드물게 존재하는 탄소 19개의 norditerpenoid 구조를 가지는 것으로 결
정되었다. 또한 입체구조는 ECD 계산을 통하여 결정할 수 있었다
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(Figure 3). 또한 기지물질인 JBIR-65의 입체구조를 결정하기 위하여
time-controlled acetylation, modified Mosher 방법과 ECD 계산이 수
행되었고, 이를 통해 이전에 밝혀지지 않았던 입체구조를 밝히는데 성공
하였다. Actinomadurol은 Staphylococcus aureus, Kocuria rhizophila, 
Proteus hauseri 등에 대하여 항박테리아 효과를 보이는 것으로 보인다.
Figure 3. The structures of actinomadurol and JBIR-65. 
4. 일본 왕개미의 장내에서 분리된 Deinococcus sp. 가 생산하는 생리활
성 이차대사물질 연구
일본왕개미(Camponotus japonicus)의 여왕개미의 장으로부터
분리된 SJN1 균주에서 네 종의 신규 aminoglycolipid를 발견하였다. 일
본왕개미는 우리나라에서 서식하는 가장 흔하고 큰 개미 중 하나로 여왕
개미가 짝짓기를 위해 혼인비행을 하는 시점인 5월에 채집되었다. 이러
한 여왕개미의 장에서 분리된 균주 SJN1은 Deinococcus sp. 로 동정되
었으며 여기서 분리된 deinococcucins A-D라 명명된 네 개의 물질 구
조는 1D, 2D NMR 분석과 질량 분석을 통해 밝혀 졌다. 분석 결과
deinococcucins은 N-acetyl glucosamine, 2,3-dihydroxypropanoic 
acid, 16~17개의 하이드로카본 체인을 가진 alkyl amine을 포함하는 것
으로 분석되었다. Deinococcucins C와 D에 포함되어 있는 olefinic 
double bond의 위치를 확인하기 위하여 olefin metathesis를 진행한 후
LC/MS로 분석하였다. N-acetyl glucosamine 와 2,3-
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dihydroxypropanoic acid의 입체구조는 기준 시료와의 GC/MS 분석과
phenylglycine methyl ester derivatization의 반응을 통해 밝혀낼 수
있었다 (Figure 4). Deinococcucins A와 C는 murine Hepa-1c1c7 
cell에 대하여 quinone reductase 활성을 나타내는 것으로 보인다. 
(a)                                
(b)
Figure 4. (a) The structures of deinococcucins A, B, C and D. (b) 
Various chemical reactions to determine the absolute configuration 
of deinococcucins.
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